background	background	NN	B-NP
atherosclerosi	atherosclerosi	NN	I-NP
and	and	CC	0
coronary	coronary	JJ	B-NP
heart	heart	NN	I-NP
disease	disease	NN	I-NP
(	(	-LRB-	0
coronary	coronary	JJ	B-NP
heart	heart	NN	I-NP
disease	disease	NN	I-NP
)	)	-RRB-	0
have	have	VBP	0
long	long	RB	0
been	been	VBN	0
considered	considered	VBN	0
major	major	JJ	0
contributor	contributor	NN	B-NP
to	to	TO	0
morbidity	morbidity	VB	0
and	and	CC	0
mortality	mortality	NN	0
in	in	IN	0
developed	developed	JJ	0
countries	countries	NNS	0
[	[	-LRB-	0
1	1	CD	0
,	,	,	0
2	2	CD	0
,	,	,	0
3	3	LS	0
]	]	-RRB-	0
.	.	.	0
One	One	PRP	0
noted	noted	VBD	B-NP
exception	exception	NN	I-NP
is	is	VBZ	0
the	the	DT	0
low	low	JJ	0
mortality	mortality	NN	0
of	of	IN	0
coronary	coronary	JJ	B-NP
heart	heart	NN	I-NP
disease	disease	NN	I-NP
in	in	IN	0
France	France	NNP	0
,	,	,	0
particularly	particularly	RB	0
the	the	DT	0
southwest	southwest	JJS	0
region	region	NN	0
[	[	-LRB-	0
4	4	CD	0
,	,	,	0
5	5	CD	0
,	,	,	0
6	6	CD	0
]	]	-RRB-	0
.	.	.	0
This	This	DT	0
phenomenon	phenomenon	NN	0
,	,	,	0
commonly	commonly	RB	0
referred	referred	VBN	0
to	to	TO	0
as	as	IN	0
the	the	DT	0
French	French	JJ	0
paradox	paradox	NN	B-NP
,	,	,	0
may	may	MD	0
be	be	VB	0
associated	associated	VBN	0
with	with	IN	0
high	high	JJ	0
consumption	consumption	NN	0
of	of	IN	0
red	red	JJ	0
wine	wine	NN	0
[	[	-LRB-	0
7	7	CD	0
,	,	,	0
8	8	CD	0
]	]	-RRB-	0
.	.	.	0
A	A	DT	0
negative	negative	JJ	B-NP
correlation	correlation	NN	I-NP
between	between	IN	0
coronary	coronary	JJ	B-NP
heart	heart	NN	I-NP
disease	disease	NN	I-NP
and	and	CC	0
alcohol	alcohol	NN	B-NP
consumption	consumption	NN	I-NP
was	was	VBD	0
first	first	RB	0
noted	noted	VBD	0
25	25	CD	0
years	years	NNS	0
ago	ago	RB	0
,	,	,	0
and	and	CC	0
numerous	numerous	JJ	B-NP
study	study	NN	I-NP
since	since	IN	0
have	have	VBP	0
confirmed	confirmed	VBN	0
a	a	DT	0
statistically	statistically	JJ	0
significant	significant	JJ	0
inverse	inverse	JJ	B-NP
relationship	relationship	NN	I-NP
between	between	IN	0
these	these	DT	0
two	two	CD	0
factors	factors	NNS	0
[	[	-LRB-	0
9	9	CD	0
,	,	,	0
10	10	CD	0
,	,	,	0
11	11	CD	0
,	,	,	0
12	12	CD	0
,	,	,	0
13	13	CD	0
,	,	,	0
14	14	CD	0
]	]	-RRB-	0
.	.	.	0
In	In	IN	0
vivo	vivo	JJ	B-NP
study	study	NN	I-NP
have	have	VBP	0
shown	shown	VBN	0
that	that	IN	0
wine	wine	NN	0
consumption	consumption	NN	0
,	,	,	0
particularly	particularly	RB	0
red	red	JJ	0
wine	wine	NN	0
,	,	,	0
is	is	VBZ	0
more	more	RBR	0
effective	effective	JJ	0
in	in	IN	0
the	the	DT	0
prevention	prevention	NN	0
of	of	IN	0
coronary	coronary	JJ	B-NP
heart	heart	NN	I-NP
disease	disease	NN	I-NP
not	not	RB	0
seen	seen	VBN	0
with	with	IN	0
other	other	JJ	0
forms	forms	NNS	0
of	of	IN	0
alcoholic	alcoholic	JJ	0
beverages	beverages	NNS	0
[	[	-LRB-	0
15	15	CD	0
,	,	,	0
16	16	CD	0
,	,	,	0
17	17	CD	0
]	]	-RRB-	0
.	.	.	0
Accordingly	Accordingly	RB	0
,	,	,	0
it	it	PRP	0
has	has	VBZ	0
been	been	VBN	0
postulated	postulated	NNS	0
that	that	WDT	0
naturally	naturally	RB	0
occurring	occurring	VBG	B-NP
component	component	JJ	I-NP
in	in	IN	0
wine	wine	NN	0
might	might	MD	0
afford	afford	VB	0
or	or	CC	0
contribute	contribute	VB	0
to	to	TO	0
its	its	PRP$	0
enhanced	enhanced	JJ	0
protection	protection	NN	0
against	against	IN	0
coronary	coronary	JJ	B-NP
heart	heart	NN	I-NP
disease	disease	NN	I-NP
by	by	IN	0
targeting	targeting	VBG	B-NP
site	site	NN	I-NP
that	that	WDT	0
participate	participate	VBP	0
in	in	IN	0
the	the	DT	0
etiology	etiology	NN	0
of	of	IN	0
coronary	coronary	JJ	B-NP
heart	heart	NN	I-NP
disease	disease	NN	I-NP
,	,	,	0
including	including	VBG	0
soluble	soluble	JJ	0
blood	blood	NN	0
components	components	NNS	0
(	(	-LRB-	0
low	low	JJ	B-NP
density	density	NN	I-NP
lipoprotein	lipoprotein	NN	I-NP
)	)	-RRB-	0
,	,	,	0
cellular	cellular	JJ	B-NP
blood	blood	NN	I-NP
element	element	NN	I-NP
(	(	-LRB-	0
platelet	platelet	NN	B-NP
)	)	-RRB-	0
,	,	,	0
or	or	CC	0
the	the	DT	0
vasculature	vasculature	NN	B-NP
itself	itself	PRP	0
(	(	-LRB-	0
endothelium	endothelium	LS	B-NP
)	)	-RRB-	0
.	.	.	0
Siemann	Siemann	NNP	B-NP
and	and	CC	0
Creasy	Creasy	NNP	0
proposed	proposed	VBD	0
that	that	IN	0
trans-resveratrol	trans-resveratrol	NNP	B-NP
,	,	,	0
a	a	DT	0
tri-hydroxy	tri-hydroxy	JJ	B-NP
stilbene	stilbene	NN	I-NP
,	,	,	0
in	in	IN	0
red	red	JJ	0
wine	wine	NN	0
exhibits	exhibits	VBZ	0
cardioprotective	cardioprotective	JJ	B-NP
property	property	NN	I-NP
[	[	-LRB-	0
18	18	CD	0
]	]	-RRB-	0
and	and	CC	0
can	can	MD	0
inhibit	inhibit	VB	0
LDL	LDL	JJ	B-NP
oxidation	oxidation	NN	I-NP
[	[	-LRB-	0
19	19	CD	0
]	]	-RRB-	0
,	,	,	0
suppress	suppress	JJ	0
smooth	smooth	JJ	0
muscle	muscle	NN	B-NP
proliferation	proliferation	NN	I-NP
[	[	-LRB-	0
20	20	CD	0
]	]	-RRB-	0
,	,	,	0
induce	induce	FW	0
nitric	nitric	JJ	B-NP
oxide	oxide	NN	I-NP
synthase	synthase	NN	I-NP
expression	expression	NN	I-NP
[	[	-LRB-	0
21	21	CD	0
]	]	-RRB-	0
and	and	CC	0
block	block	VB	0
collagen-induced	collagen-induced	JJ	B-NP
aggregation	aggregation	JJ	I-NP
response	response	NN	I-NP
in	in	IN	0
washed	washed	JJ	0
platelet	platelet	NN	B-NP
[	[	-LRB-	0
22	22	CD	0
,	,	,	0
23	23	CD	0
,	,	,	0
24	24	CD	0
]	]	-RRB-	0
.	.	.	0
However	However	RB	0
,	,	,	0
relatively	relatively	RB	0
few	few	JJ	0
studies	studies	NNS	0
have	have	VBP	0
been	been	VBN	0
performed	performed	VBN	0
on	on	IN	0
the	the	DT	0
effects	effects	NNS	0
of	of	IN	0
resveratrol	resveratrol	NN	B-NP
on	on	IN	0
vascular	vascular	JJ	B-NP
component	component	JJ	I-NP
such	such	JJ	0
as	as	IN	0
the	the	DT	0
endothelial	endothelial	JJ	B-NP
cell	cell	NN	I-NP
,	,	,	0
which	which	WDT	0
are	are	VBP	0
known	known	VBN	0
to	to	TO	0
play	play	VB	0
a	a	DT	0
critical	critical	JJ	B-NP
role	role	NN	I-NP
in	in	IN	0
maintaining	maintaining	VBG	0
the	the	DT	0
integrity	integrity	NN	0
and	and	CC	0
functioning	functioning	VBG	0
of	of	IN	0
the	the	DT	0
vascular	vascular	JJ	B-NP
endothelium	endothelium	NN	I-NP
.	.	.	0
vascular	vascular	JJ	B-NP
endothelium	endothelium	NN	I-NP
homeostasi	homeostasi	NN	I-NP
,	,	,	0
both	both	DT	0
with	with	IN	0
respect	respect	NN	0
to	to	TO	0
metabolic	metabolic	VB	0
and	and	CC	0
physiologic	physiologic	JJ	B-NP
activity	activity	NN	I-NP
,	,	,	0
can	can	MD	0
be	be	VB	0
affected	affected	VBN	0
by	by	IN	0
overall	overall	JJ	0
nutritional	nutritional	JJ	B-NP
status	status	NN	I-NP
and	and	CC	0
by	by	IN	0
specific	specific	JJ	0
ingredients	ingredients	NNS	0
in	in	IN	0
the	the	DT	0
diet	diet	NN	0
[	[	-LRB-	0
25	25	CD	0
,	,	,	0
26	26	CD	0
,	,	,	0
27	27	CD	0
]	]	-RRB-	0
.	.	.	0
The	The	DT	0
aims	aims	NNS	0
of	of	IN	0
the	the	DT	0
present	present	JJ	0
study	study	NN	0
were	were	VBD	0
to	to	TO	0
determine	determine	VB	0
changes	changes	NNS	0
resulting	resulting	VBG	0
from	from	IN	0
resveratrol	resveratrol	NN	B-NP
:	:	:	0
endothelial	endothelial	JJ	B-NP
cell	cell	NN	I-NP
interaction	interaction	NN	I-NP
.	.	.	0
We	We	PRP	0
observed	observed	VBD	0
that	that	DT	0
resveratrol	resveratrol	JJ	B-NP
induced	induced	JJ	I-NP
significant	significant	JJ	I-NP
cellular	cellular	JJ	I-NP
and	and	CC	0
biochemical	biochemical	JJ	B-NP
change	change	NN	I-NP
in	in	IN	0
endothelial	endothelial	JJ	B-NP
cell	cell	NN	I-NP
,	,	,	0
which	which	WDT	0
were	were	VBD	0
accompanied	accompanied	VBN	0
by	by	IN	0
altered	altered	JJ	0
functional	functional	JJ	B-NP
responsiveness	responsiveness	NN	I-NP
to	to	TO	0
conditions	conditions	NNS	0
simulating	simulating	VBP	0
arterial	arterial	JJ	B-NP
flow	flow	NN	I-NP
.	.	.	0
Since	Since	IN	0
previous	previous	JJ	0
studies	studies	NNS	0
have	have	VBP	0
shown	shown	VBN	0
several	several	JJ	0
signaling	signaling	JJ	0
molecule	molecule	NN	B-NP
change	change	NN	I-NP
during	during	IN	0
endothelial	endothelial	NN	B-NP
cell	cell	NN	I-NP
cytoskeleton	cytoskeleton	NN	I-NP
reorganization	reorganization	NN	I-NP
accompanying	accompanying	FW	0
arterial	arterial	FW	0
shear	shear	FW	0
stress	stress	FW	0
[	[	-LRB-	0
28	28	CD	0
,	,	,	0
29	29	CD	0
,	,	,	0
30	30	CD	0
,	,	,	0
31	31	CD	0
]	]	-RRB-	0
,	,	,	0
we	we	PRP	0
evaluated	evaluated	VBD	0
the	the	DT	0
same	same	JJ	0
set	set	NN	0
of	of	IN	0
biochemical	biochemical	JJ	B-NP
parameter	parameter	NN	I-NP
in	in	IN	0
resveratrol-treated	resveratrol-treated	JJ	B-NP
cell	cell	NN	I-NP
.	.	.	0
Use	Use	NN	0
of	of	IN	0
selective	selective	JJ	B-NP
signaling	signaling	JJ	I-NP
pathway	pathway	NNS	I-NP
inhibitor	inhibitor	NN	I-NP
allowed	allowed	VBN	0
the	the	DT	0
demonstration	demonstration	NN	B-NP
that	that	IN	0
the	the	DT	0
cytoskeletal	cytoskeletal	JJ	B-NP
change	change	NN	I-NP
elicited	elicited	VBN	0
by	by	IN	0
resveratrol	resveratrol	JJ	B-NP
depended	depended	NN	I-NP
on	on	IN	0
intracellular	intracellular	JJ	B-NP
calcium	calcium	NN	I-NP
and	and	CC	0
tyrosine	tyrosine	JJ	B-NP
kinase	kinase	JJ	I-NP
activity	activity	NN	I-NP
change	change	NN	I-NP
,	,	,	0
and	and	CC	0
also	also	RB	0
appeared	appeared	VBD	0
to	to	TO	0
be	be	VB	0
linked	linked	VBN	0
to	to	TO	0
integrity	integrity	NN	0
of	of	IN	0
actin	actin	JJ	B-NP
microfilament	microfilament	NN	I-NP
and	and	CC	0
microtubule	microtubule	JJ	B-NP
network	network	NN	I-NP
.	.	.	0
Resveratrol	Resveratrol	JJ	B-NP
treatment	treatment	NN	I-NP
also	also	RB	0
led	led	VBN	0
to	to	TO	0
erk1	erk1	NN	B-NP
activation	activation	VB	I-NP
/	/	CD	0
2	2	CD	0
MAP	MAP	JJ	B-NP
kinase	kinase	NN	I-NP
,	,	,	0
similar	similar	JJ	0
to	to	TO	0
changes	changes	NNS	0
induced	induced	VBN	0
by	by	IN	0
shear	shear	NNS	0
[	[	-LRB-	0
30	30	CD	0
,	,	,	0
31	31	CD	0
]	]	-RRB-	0
.	.	.	0
Thus	Thus	RB	0
resveratrol	resveratrol	RB	0
may	may	MD	0
act	act	VB	0
by	by	IN	0
a	a	DT	0
mechanism	mechanism	NN	B-NP
closely	closely	RB	0
resembling	resembling	VBG	0
that	that	IN	0
triggered	triggered	VBN	0
by	by	IN	0
shear	shear	JJ	0
stress	stress	NN	0
.	.	.	0
Results	Results	NNP	0
Resveratrol	Resveratrol	NNP	B-NP
induces	induces	VBZ	0
morphologic	morphologic	JJ	B-NP
change	change	NN	I-NP
in	in	IN	0
endothelial	endothelial	JJ	B-NP
cell	cell	NN	I-NP
Sterilized	Sterilized	JJ	0
plastic	plastic	NN	0
18	18	CD	0
mm	mm	CD	0
×	×	CD	0
21	21	CD	0
mm	mm	CD	B-NP
coverslip	coverslip	NN	I-NP
were	were	VBD	0
seeded	seeded	VBN	0
with	with	IN	0
BPAEC	BPAEC	NNP	B-NP
and	and	CC	0
treated	treated	VBD	0
24	24	CD	0
h	h	NNS	0
later	later	RB	0
with	with	IN	0
various	various	JJ	0
resveratrol	resveratrol	NN	B-NP
concentration	concentration	NN	I-NP
.	.	.	0
Following	Following	VBG	0
an	an	DT	0
additional	additional	JJ	0
2	2	CD	0
day	day	NN	0
of	of	IN	0
culture	culture	NN	0
,	,	,	0
the	the	DT	0
coverslip	coverslip	NN	B-NP
containing	containing	VBG	0
the	the	DT	0
attached	attached	JJ	0
bpaec	bpaec	NN	B-NP
were	were	VBD	0
fixed	fixed	VBN	B-NP
,	,	,	0
stained	stained	VBG	0
with	with	IN	0
rhodamine-phalloidin	rhodamine-phalloidin	NNP	B-NP
,	,	,	0
and	and	CC	0
mounted	mounted	VBN	0
onto	onto	IN	0
slides	slides	NNS	0
for	for	IN	0
analysis	analysis	NN	0
by	by	IN	0
confocal	confocal	JJ	B-NP
microscopy	microscopy	NN	I-NP
.	.	.	0
The	The	DT	0
polyphenol	polyphenol	NN	B-NP
(	(	-LRB-	0
100	100	CD	0
μM	μM	NN	B-NP
)	)	-RRB-	0
had	had	VBD	0
a	a	DT	0
distinct	distinct	JJ	0
morphologic	morphologic	JJ	B-NP
effect	effect	NN	I-NP
,	,	,	0
changing	changing	VBG	0
the	the	DT	0
cells	cells	NNS	0
from	from	IN	0
a	a	DT	0
boxy	boxy	JJ	0
,	,	,	0
cobblestone-like	cobblestone-like	JJ	B-NP
appearance	appearance	NN	I-NP
(	(	-LRB-	0
panel	panel	NN	0
A	A	NN	0
,	,	,	0
Fig.	Fig.	CD	0
1	1	CD	0
)	)	-RRB-	0
to	to	TO	0
an	an	DT	0
elongated	elongated	NN	0
,	,	,	0
ellipsoidal	ellipsoidal	JJ	B-NP
shape	shape	NN	I-NP
with	with	IN	0
long	long	JJ	0
,	,	,	0
tortuous	tortuous	JJ	B-NP
process	process	NN	I-NP
(	(	-LRB-	0
panel	panel	NN	B-NP
B	B	NNP	I-NP
)	)	-RRB-	0
.	.	.	0
As	As	IN	0
little	little	JJ	0
as	as	IN	0
25	25	CD	0
μM	μM	JJ	B-NP
resveratrol	resveratrol	NN	I-NP
sufficed	sufficed	VBD	0
to	to	TO	0
induce	induce	VB	0
these	these	DT	0
cellular	cellular	JJ	B-NP
change	change	NN	I-NP
,	,	,	0
in	in	IN	0
passage	passage	NN	0
4-7	4-7	CD	0
cells	cells	NNS	0
(	(	-LRB-	0
compare	compare	VB	0
panel	panel	NN	0
C	C	NNP	0
with	with	IN	0
panel	panel	NN	0
A	A	NN	0
,	,	,	0
Fig.	Fig.	CD	0
2	2	CD	0
)	)	-RRB-	0
.	.	.	0
To	To	TO	0
quantify	quantify	VB	0
the	the	DT	0
percentages	percentages	NNS	0
of	of	IN	0
cells	cells	NNS	0
with	with	IN	0
the	the	DT	0
elongated	elongated	JJ	0
morphology	morphology	NN	0
,	,	,	0
a	a	DT	0
minimum	minimum	NN	0
of	of	IN	0
300	300	CD	0
cells	cells	NNS	0
in	in	IN	0
representative	representative	JJ	B-NP
microscopic	microscopic	JJ	I-NP
field	field	NN	I-NP
were	were	VBD	0
counted	counted	VBN	0
and	and	CC	0
the	the	DT	0
results	results	NNS	0
presented	presented	VBN	0
in	in	IN	0
Fig.	Fig.	CD	0
3	3	CD	0
.	.	.	0
The	The	DT	0
percentage	percentage	NN	0
of	of	IN	0
cells	cells	NNS	0
showing	showing	VBG	0
the	the	DT	0
elongated	elongated	JJ	0
phenotype	phenotype	NN	B-NP
is	is	VBZ	0
proportional	proportional	VBN	0
to	to	TO	0
the	the	DT	0
resveratrol	resveratrol	NN	B-NP
concentration	concentration	NN	I-NP
added	added	VBD	0
to	to	TO	0
the	the	DT	0
culture	culture	NN	0
.	.	.	0
Treatment	Treatment	NN	0
with	with	IN	0
resveratrol	resveratrol	VBG	0
also	also	RB	0
suppressed	suppressed	JJ	0
growth	growth	NN	0
of	of	IN	0
BPAEC	BPAEC	NNP	0
(	(	-LRB-	0
data	data	NNS	0
not	not	RB	0
shown	shown	VBN	0
)	)	-RRB-	0
,	,	,	0
as	as	IN	0
we	we	PRP	0
previously	previously	RB	0
reported	reported	VBD	0
[	[	-LRB-	0
21	21	CD	0
]	]	-RRB-	0
.	.	.	0
Resveratrol	Resveratrol	JJ	B-NP
treatment	treatment	NN	I-NP
leads	leads	VBZ	0
to	to	TO	0
increased	increased	JJ	0
adherence	adherence	NN	0
of	of	IN	0
BPAEC	BPAEC	NNP	B-NP
under	under	IN	0
simulated	simulated	JJ	0
arterial	arterial	JJ	B-NP
flow	flow	NN	I-NP
condition	condition	NN	I-NP
To	To	TO	0
test	test	VB	0
whether	whether	IN	0
functional	functional	JJ	B-NP
change	change	NN	I-NP
may	may	MD	0
accompany	accompany	VB	0
the	the	DT	0
modified	modified	JJ	0
morphology	morphology	NN	0
,	,	,	0
control	control	NN	0
and	and	CC	0
2	2	CD	0
day	day	NN	0
and	and	CC	0
100	100	CD	0
μm	μm	NN	B-NP
resveratrol-treated	resveratrol-treated	JJ	I-NP
cell	cell	NN	I-NP
were	were	VBD	0
exposed	exposed	VBN	0
to	to	TO	0
0	0	CD	0
min	min	NN	B-NP
(	(	-LRB-	0
control	control	NN	0
)	)	-RRB-	0
,	,	,	0
2	2	CD	0
min	min	NN	B-NP
,	,	,	0
or	or	CC	0
5	5	CD	0
min	min	NN	B-NP
of	of	IN	0
simulated	simulated	JJ	0
arterial	arterial	JJ	0
shear	shear	NNS	0
stress	stress	VBP	0
using	using	VBG	0
a	a	DT	0
parallel	parallel	JJ	0
plate	plate	NN	B-NP
perfusion	perfusion	NN	I-NP
chamber	chamber	NN	I-NP
(	(	-LRB-	0
see	see	VB	0
Materials	Materials	NNPS	0
and	and	CC	0
Methods	Methods	NNP	0
)	)	-RRB-	0
.	.	.	0
Following	Following	VBG	0
the	the	DT	0
shear	shear	JJ	0
challenge	challenge	NN	0
,	,	,	0
cells	cells	NNS	0
remaining	remaining	VBG	0
attached	attached	VBN	0
were	were	VBD	0
scored	scored	VBN	0
by	by	IN	0
staining	staining	NN	0
with	with	IN	0
rhodamine-phalloidin	rhodamine-phalloidin	NNP	B-NP
,	,	,	0
as	as	RB	0
described	described	VBN	0
.	.	.	0
Since	Since	IN	0
the	the	DT	0
cells	cells	NNS	0
were	were	VBD	0
evenly	evenly	RB	0
distributed	distributed	VBN	0
throughout	throughout	IN	0
the	the	DT	0
area	area	NN	0
of	of	IN	0
the	the	DT	0
coverslip	coverslip	NN	B-NP
exposed	exposed	VBN	0
to	to	TO	0
flow	flow	VB	0
,	,	,	0
representative	representative	JJ	B-NP
picture	picture	NN	I-NP
were	were	VBD	0
taken	taken	VBN	0
of	of	IN	0
the	the	DT	0
confocal	confocal	JJ	B-NP
microscopy	microscopy	JJ	I-NP
field	field	NN	I-NP
located	located	VBN	0
directly	directly	RB	0
in	in	IN	0
the	the	DT	0
center	center	NN	0
of	of	IN	0
the	the	DT	0
coverslip	coverslip	NN	B-NP
,	,	,	0
and	and	CC	0
the	the	DT	0
number	number	NN	0
of	of	IN	0
cells	cells	NNS	0
were	were	VBD	0
counted	counted	VBN	0
.	.	.	0
As	As	RB	0
can	can	MD	0
be	be	VB	0
seen	seen	VBN	0
in	in	IN	0
Fig.	Fig.	CD	0
4	4	CD	0
,	,	,	0
compared	compared	VBN	0
to	to	TO	0
the	the	DT	0
0	0	CD	0
min	min	JJ	B-NP
sample	sample	NN	I-NP
,	,	,	0
a	a	DT	0
significant	significant	JJ	0
percentage	percentage	NN	0
of	of	IN	0
resveratrol-treated	resveratrol-treated	NNP	B-NP
BPAEC	BPAEC	NNP	I-NP
remained	remained	VBD	0
attached	attached	VBN	0
to	to	TO	0
the	the	DT	0
plastic	plastic	JJ	B-NP
coverslip	coverslip	NN	I-NP
after	after	IN	0
2	2	CD	0
min	min	NN	B-NP
and	and	CC	0
5	5	CD	0
min	min	JJ	B-NP
flow	flow	NN	I-NP
challenge	challenge	NN	I-NP
.	.	.	0
In	In	IN	0
comparison	comparison	NN	0
,	,	,	0
under	under	IN	0
identical	identical	JJ	0
experimental	experimental	JJ	B-NP
condition	condition	NN	I-NP
,	,	,	0
cells	cells	NNS	0
adhering	adhering	VBP	0
to	to	TO	0
the	the	DT	0
coverslip	coverslip	NN	B-NP
decreased	decreased	VBD	0
dramatically	dramatically	RB	0
in	in	IN	0
controls	controls	NNS	0
,	,	,	0
with	with	IN	0
virtually	virtually	RB	0
no	no	DT	0
cells	cells	NNS	0
remaining	remaining	VBG	0
after	after	IN	0
a	a	DT	0
5	5	CD	0
min	min	CD	B-NP
simulated	simulated	JJ	0
flow	flow	NN	0
.	.	.	0
These	These	DT	0
results	results	NNS	0
suggest	suggest	VBP	0
that	that	IN	0
a	a	DT	0
functional	functional	JJ	B-NP
alteration	alteration	NN	I-NP
,	,	,	0
measured	measured	VBN	0
by	by	IN	0
greater	greater	JJR	0
adherence	adherence	NN	0
of	of	IN	0
cells	cells	NNS	0
under	under	IN	0
simulated	simulated	JJ	0
arterial	arterial	JJ	B-NP
flow	flow	NN	I-NP
condition	condition	NN	I-NP
,	,	,	0
accompanied	accompanied	VBN	0
the	the	DT	0
change	change	NN	0
in	in	IN	0
cellular	cellular	JJ	B-NP
phenotype	phenotype	NN	I-NP
,	,	,	0
following	following	VBG	0
treatment	treatment	NN	0
with	with	IN	0
resveratrol	resveratrol	NN	B-NP
.	.	.	0
Effect	Effect	NN	0
of	of	IN	0
cell	cell	NN	0
signaling	signaling	VBG	B-NP
inhibitor	inhibitor	NN	I-NP
on	on	IN	0
cell	cell	NN	0
elongation	elongation	VBZ	0
induced	induced	VBN	0
by	by	IN	0
resveratrol	resveratrol	JJ	B-NP
further	further	JJ	I-NP
insight	insight	NN	I-NP
into	into	IN	0
the	the	DT	0
nature	nature	NN	0
of	of	IN	0
the	the	DT	0
resveratrol-induced	resveratrol-induced	JJ	B-NP
morphologcial	morphologcial	JJ	I-NP
change	change	NN	I-NP
came	came	VBD	0
from	from	IN	0
studies	studies	NNS	0
using	using	VBG	0
selective	selective	JJ	B-NP
inhibitor	inhibitor	NN	I-NP
for	for	IN	0
different	different	JJ	0
signaling	signaling	JJ	0
pathways	pathways	NN	0
.	.	.	0
These	These	DT	0
include	include	VBP	0
:	:	:	0
quin2-AM	quin2-AM	CD	B-NP
(	(	-LRB-	0
intracellular	intracellular	NN	B-NP
[	[	-LRB-	0
Ca	Ca	NNP	B-NP
2+	2+	NNP	0
]	]	-RRB-	0
)	)	-RRB-	0
,	,	,	0
herbimycin	herbimycin	VBG	0
A	A	DT	0
(	(	-LRB-	0
tyrosine	tyrosine	NN	B-NP
kinas	kinas	NNP	I-NP
)	)	-RRB-	0
,	,	,	0
chelerythrina	chelerythrina	NN	B-NP
(	(	-LRB-	0
PKC	PKC	NNP	B-NP
)	)	-RRB-	0
,	,	,	0
cytochalasin	cytochalasin	VBG	0
D	D	NNP	0
(	(	-LRB-	0
actin	actin	NN	B-NP
microfilament	microfilament	NN	I-NP
)	)	-RRB-	0
,	,	,	0
and	and	CC	0
nocodazola	nocodazola	NN	B-NP
(	(	-LRB-	0
disassembly	disassembly	NN	0
of	of	IN	0
microtubule	microtubule	NN	B-NP
)	)	-RRB-	0
.	.	.	0
Cells	Cells	NNS	0
were	were	VBD	0
treated	treated	VBN	0
with	with	IN	0
inhibitors	inhibitors	NN	0
,	,	,	0
at	at	IN	0
concentration	concentration	NN	B-NP
indicated	indicated	VBD	0
in	in	IN	0
Materials	Materials	NNPS	0
and	and	CC	0
Methods	Methods	NNP	0
,	,	,	0
and	and	CC	0
then	then	RB	0
exposed	exposed	VBN	0
to	to	TO	0
resveratrol	resveratrol	VB	0
.	.	.	0
Representative	Representative	NNP	B-NP
confocal	confocal	VBD	0
microscopy	microscopy	JJ	0
fields	fields	NNS	0
for	for	IN	0
both	both	DT	0
control	control	NN	0
and	and	CC	0
resveratrol-treated	resveratrol-treated	JJ	B-NP
cell	cell	NN	I-NP
were	were	VBD	0
counted	counted	VBN	0
for	for	IN	0
elongated	elongated	NN	0
and	and	CC	0
non-elongated	non-elongated	JJ	B-NP
cell	cell	NN	I-NP
.	.	.	0
The	The	DT	0
inhibitors	inhibitors	NN	0
used	used	VBD	0
noticeably	noticeably	RB	0
suppressed	suppressed	JJ	0
cell	cell	NN	B-NP
growth	growth	NN	I-NP
(	(	-LRB-	0
particularly	particularly	RB	0
treatment	treatment	NN	0
with	with	IN	0
cytochalasin	cytochalasin	JJ	0
D	D	NNP	0
and	and	CC	0
nocodazole	nocodazole	CD	B-NP
)	)	-RRB-	0
,	,	,	0
particularly	particularly	RB	0
controls	controls	VBZ	0
not	not	RB	0
treated	treated	VBN	0
with	with	IN	0
resveratrol	resveratrol	NN	B-NP
.	.	.	0
The	The	DT	0
degree	degree	NN	0
of	of	IN	0
growth	growth	NN	B-NP
inhibition	inhibition	VBZ	I-NP
varied	varied	VBN	0
,	,	,	0
depending	depending	VBG	0
on	on	IN	0
primary	primary	JJ	B-NP
bpaec	bpaec	NN	I-NP
preparation	preparation	NN	I-NP
.	.	.	0
Interestingly	Interestingly	RB	0
,	,	,	0
cells	cells	NNS	0
treated	treated	VBN	0
with	with	IN	0
resveratrol	resveratrol	NN	B-NP
,	,	,	0
which	which	WDT	0
had	had	VBD	0
to	to	TO	0
be	be	VB	0
reduced	reduced	VBN	0
to	to	TO	0
40	40	CD	0
h	h	NN	0
because	because	IN	0
of	of	IN	0
adverse	adverse	JJ	0
responses	responses	NNS	0
of	of	IN	0
control	control	NN	B-NP
cell	cell	NN	I-NP
to	to	TO	0
inhibitors	inhibitors	VB	0
(	(	-LRB-	0
see	see	VB	0
Materials	Materials	NNPS	0
and	and	CC	0
Methods	Methods	NNP	0
)	)	-RRB-	0
,	,	,	0
afforded	afforded	VBN	0
better	better	JJR	0
growth	growth	NN	B-NP
in	in	IN	0
samples	samples	NNS	0
containing	containing	VBG	0
the	the	DT	0
inhibitors	inhibitors	NN	0
.	.	.	0
Table	Table	NN	0
1summarized	1summarized	CD	0
results	results	NNS	0
averaged	averaged	VBD	0
from	from	IN	0
4	4	CD	0
separate	separate	JJ	0
experiments	experiments	NNS	0
,	,	,	0
each	each	DT	0
performed	performed	VBN	0
with	with	IN	0
a	a	DT	0
different	different	JJ	0
primary	primary	JJ	B-NP
bpaec	bpaec	NN	I-NP
preparation	preparation	NN	I-NP
.	.	.	0
Since	Since	IN	0
control	control	NN	B-NP
cell	cell	NN	I-NP
growth	growth	NN	I-NP
as	as	IN	0
well	well	RB	0
as	as	IN	0
their	their	PRP$	0
response	response	NN	0
to	to	TO	0
resveratrol	resveratrol	VB	0
and	and	CC	0
addition	addition	NN	B-NP
of	of	IN	0
inhibitors	inhibitors	JJ	0
differed	differed	NN	0
between	between	IN	0
bpaec	bpaec	NN	B-NP
preparation	preparation	NN	I-NP
,	,	,	0
cells	cells	NNS	0
showing	showing	VBG	0
the	the	DT	0
elongated	elongated	JJ	0
shape	shape	NN	0
in	in	IN	0
each	each	DT	0
experiment	experiment	NN	0
were	were	VBD	0
calculated	calculated	VBN	0
as	as	IN	0
a	a	DT	0
percent	percent	NN	0
of	of	IN	0
total	total	JJ	B-NP
cell	cell	NN	I-NP
counted	counted	VBN	0
(	(	-LRB-	0
ranging	ranging	VBG	0
from	from	IN	0
60-700	60-700	CD	0
)	)	-RRB-	0
.	.	.	0
The	The	DT	0
numbers	numbers	NNS	0
obtained	obtained	VBN	0
in	in	IN	0
this	this	DT	0
manner	manner	NN	0
were	were	VBD	0
used	used	VBN	0
to	to	TO	0
calculate	calculate	VB	0
the	the	DT	0
mean	mean	NN	B-NP
(	(	-LRB-	0
%	%	NN	0
)	)	-RRB-	0
±	±	NNP	0
SD	SD	NNP	B-NP
,	,	,	0
as	as	RB	0
shown	shown	VBN	0
.	.	.	0
chelerythrine	chelerythrine	NN	B-NP
addition	addition	NN	I-NP
,	,	,	0
an	an	DT	0
inhibitor	inhibitor	NN	0
of	of	IN	0
protein	protein	NN	B-NP
kinase	kinase	VBD	0
C	C	NNP	0
,	,	,	0
caused	caused	VBD	0
a	a	DT	0
significant	significant	JJ	0
increase	increase	NN	0
in	in	IN	0
percentage	percentage	NN	0
of	of	IN	0
elongated	elongated	JJ	0
cells	cells	NNS	0
alone	alone	RB	0
and	and	CC	0
did	did	VBD	0
not	not	RB	0
affect	affect	VB	0
morphologic	morphologic	JJ	B-NP
response	response	NN	I-NP
of	of	IN	0
cells	cells	NNS	0
to	to	TO	0
resveratrol	resveratrol	VB	0
.	.	.	0
Inhibitors	Inhibitors	NNP	0
of	of	IN	0
intracellular	intracellular	NN	B-NP
[	[	-LRB-	0
Ca	Ca	NNP	B-NP
2+	2+	NNP	0
]	]	-RRB-	0
and	and	CC	0
tyrosine	tyrosine	JJ	B-NP
kinase	kinase	JJ	I-NP
activity	activity	NN	I-NP
effectively	effectively	RB	0
reduced	reduced	VBN	0
the	the	DT	0
percentage	percentage	NN	0
of	of	IN	0
elongated	elongated	JJ	0
cells	cells	NNS	0
elicited	elicited	VBN	0
by	by	IN	0
resveratrol	resveratrol	NN	B-NP
.	.	.	0
Results	Results	NNS	0
in	in	IN	0
Table	Table	NNP	0
1further	1further	NNP	0
showed	showed	VBD	0
that	that	DT	0
cytoskeletal	cytoskeletal	JJ	B-NP
change	change	NN	I-NP
elicited	elicited	VBN	0
by	by	IN	0
resveratrol	resveratrol	VBG	0
also	also	RB	0
appeared	appeared	VBD	0
to	to	TO	0
be	be	VB	0
linked	linked	VBN	0
to	to	TO	0
integrity	integrity	NN	0
of	of	IN	0
actin	actin	JJ	B-NP
microfilament	microfilament	NN	I-NP
and	and	CC	0
microtubule	microtubule	JJ	B-NP
network	network	NN	I-NP
as	as	IN	0
the	the	DT	0
morphologic	morphologic	JJ	B-NP
change	change	NN	I-NP
were	were	VBD	0
also	also	RB	0
substantially	substantially	RB	0
lowered	lowered	VBN	0
in	in	IN	0
cells	cells	NNS	0
treated	treated	VBN	0
with	with	IN	0
cytochalasin	cytochalasin	JJ	0
D	D	NNP	0
and	and	CC	0
nocodazole	nocodazole	NN	B-NP
,	,	,	0
which	which	WDT	0
inhibit	inhibit	VBP	0
formation	formation	NN	0
of	of	IN	0
actin	actin	JJ	B-NP
microfilament	microfilament	NN	I-NP
and	and	CC	0
microtubule	microtubule	JJ	B-NP
network	network	NN	I-NP
,	,	,	0
respectively	respectively	RB	0
.	.	.	0
Effect	Effect	NN	0
of	of	IN	0
resveratrol	resveratrol	NN	B-NP
on	on	IN	0
ERK1	ERK1	CD	B-NP
/	/	CD	0
2	2	CD	0
activation	activation	NN	B-NP
and	and	CC	0
eIF4E	eIF4E	NNP	0
,	,	,	0
biochemical	biochemical	JJ	B-NP
change	change	NN	I-NP
enos	enos	NNP	I-NP
expression	expression	NN	I-NP
in	in	IN	0
resveratrol-treated	resveratrol-treated	NNP	B-NP
BPAEC	BPAEC	NNP	I-NP
were	were	VBD	0
assessed	assessed	VBN	0
by	by	IN	0
western	western	JJ	0
blot	blot	JJ	0
analyses	analyses	NNS	0
.	.	.	0
Fig.	Fig.	NNP	0
5shows	5shows	NNP	0
that	that	IN	0
in	in	IN	0
control	control	NN	B-NP
cell	cell	NN	I-NP
,	,	,	0
level	level	NN	0
of	of	IN	0
active	active	JJ	0
ERK1	ERK1	NNP	B-NP
/	/	NNP	0
2-P	2-P	NNP	B-NP
remained	remained	VBD	0
relatively	relatively	RB	0
constant	constant	VB	0
up	up	RP	0
to	to	TO	0
48	48	CD	0
h	h	NNS	0
but	but	CC	0
showed	showed	VBD	0
a	a	DT	0
precipitous	precipitous	JJ	B-NP
decline	decline	NN	I-NP
from	from	IN	0
48	48	CD	0
to	to	TO	0
96	96	CD	0
h	h	NNS	0
(	(	-LRB-	0
panel	panel	NN	0
A	A	NNP	0
)	)	-RRB-	0
.	.	.	0
Under	Under	IN	0
the	the	DT	0
same	same	JJ	0
conditions	conditions	NNS	0
,	,	,	0
levels	levels	NNS	0
of	of	IN	0
total	total	JJ	B-NP
ERK1	ERK1	CD	I-NP
/	/	CD	0
2	2	CD	0
(	(	-LRB-	0
panel	panel	NN	B-NP
B	B	NNP	I-NP
)	)	-RRB-	0
,	,	,	0
eIF4E	eIF4E	NNP	0
(	(	-LRB-	0
panel	panel	NN	0
C	C	NNP	0
)	)	-RRB-	0
,	,	,	0
a	a	DT	0
downstream	downstream	JJ	0
erk1	erk1	NN	B-NP
effector	effector	NN	I-NP
/	/	CD	0
ERK2	ERK2	CD	B-NP
,	,	,	0
and	and	CC	0
actin	actin	NN	B-NP
(	(	-LRB-	0
panel	panel	NN	B-NP
E	E	NN	I-NP
)	)	-RRB-	0
showed	showed	VBD	0
no	no	DT	0
substantial	substantial	JJ	0
change	change	NN	0
at	at	IN	0
all	all	DT	0
time	time	NN	B-NP
point	point	NN	I-NP
assayed	assayed	NN	0
,	,	,	0
in	in	IN	0
control	control	NN	B-NP
cell	cell	NN	I-NP
.	.	.	0
Treatment	Treatment	NN	0
with	with	IN	0
25	25	CD	0
μM	μM	JJ	0
and	and	CC	0
100	100	CD	0
μM	μM	JJ	B-NP
resveratrol	resveratrol	NN	I-NP
prevented	prevented	VBD	0
the	the	DT	0
decrease	decrease	NN	0
in	in	IN	0
active	active	JJ	0
ERK1	ERK1	CD	B-NP
/	/	CD	0
2-P	2-P	CD	B-NP
seen	seen	VBN	0
at	at	IN	0
96	96	CD	0
h	h	NNS	0
(	(	-LRB-	0
panel	panel	NN	0
A	A	NN	0
,	,	,	0
last	last	JJ	0
3	3	CD	0
lanes	lanes	NNS	0
)	)	-RRB-	0
.	.	.	0
In	In	IN	0
addition	addition	NN	B-NP
,	,	,	0
these	these	DT	0
concentration	concentration	NN	B-NP
of	of	IN	0
resveratrol	resveratrol	VBG	0
markedly	markedly	RB	0
increased	increased	VBN	B-NP
eNOS	eNOS	JJ	I-NP
expression	expression	NN	I-NP
as	as	IN	0
early	early	JJ	0
as	as	IN	0
6-h	6-h	NNP	B-NP
,	,	,	0
which	which	WDT	0
reached	reached	VBD	0
maximum	maximum	JJ	0
induction	induction	NN	B-NP
at	at	IN	0
48-h	48-h	NNP	0
,	,	,	0
and	and	CC	0
remained	remained	VBD	0
substantially	substantially	RB	0
elevated	elevated	VBD	0
at	at	IN	0
96-h	96-h	NNP	0
(	(	-LRB-	0
panel	panel	NN	0
D	D	NNP	0
)	)	-RRB-	0
.	.	.	0
total	total	JJ	B-NP
erk1	erk1	NN	I-NP
relative	relative	JJ	I-NP
change	change	NN	I-NP
quantification	quantification	NN	I-NP
/	/	CD	0
2	2	CD	0
,	,	,	0
active	active	JJ	0
ERK1	ERK1	CD	B-NP
/	/	CD	0
2-P	2-P	CD	B-NP
,	,	,	0
and	and	CC	0
enzyme	enzyme	NN	B-NP
nitric	nitric	JJ	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
oxide	oxide	NN	I-NP
synthase	synthase	NN	I-NP
as	as	IN	0
a	a	DT	0
function	function	NN	0
of	of	IN	0
time	time	NN	0
of	of	IN	0
treatment	treatment	NN	0
with	with	IN	0
two	two	CD	0
resveratrol	resveratrol	NN	B-NP
concentration	concentration	NN	I-NP
is	is	VBZ	0
depicted	depicted	VBN	0
in	in	IN	0
Figure	Figure	NNP	0
6	6	CD	0
.	.	.	0
Discussion	Discussion	NNP	0
endothelial	endothelial	JJ	B-NP
cell	cell	NN	I-NP
shape	shape	NN	I-NP
modulation	modulation	NN	I-NP
by	by	IN	0
resveratrol	resveratrol	JJ	B-NP
Size	Size	NN	I-NP
,	,	,	0
shape	shape	NN	0
,	,	,	0
mutual	mutual	JJ	B-NP
orientation	orientation	NN	I-NP
,	,	,	0
and	and	CC	0
intercellular	intercellular	JJ	B-NP
contact	contact	NN	I-NP
in	in	IN	0
endothelium	endothelium	NN	B-NP
are	are	VBP	0
not	not	RB	0
incidental	incidental	JJ	0
and	and	CC	0
statistic	statistic	JJ	B-NP
event	event	NN	I-NP
,	,	,	0
but	but	CC	0
are	are	VBP	0
precisely	precisely	RB	0
and	and	CC	0
dynamically	dynamically	VB	0
regulated	regulated	VBN	0
.	.	.	0
endothelial	endothelial	JJ	B-NP
cell	cell	NN	I-NP
shape	shape	NN	I-NP
reversible	reversible	JJ	I-NP
change	change	NN	I-NP
,	,	,	0
mutual	mutual	JJ	B-NP
orientation	orientation	NN	I-NP
of	of	IN	0
cells	cells	NNS	0
in	in	IN	0
certain	certain	JJ	0
directions	directions	NNS	0
,	,	,	0
changes	changes	NNS	0
in	in	IN	0
intercellular	intercellular	JJ	B-NP
contact	contact	NN	I-NP
,	,	,	0
are	are	VBP	0
controlled	controlled	VBN	0
by	by	IN	0
a	a	DT	0
number	number	NN	0
of	of	IN	0
factors	factors	NNS	0
,	,	,	0
such	such	JJ	0
as	as	RB	0
,	,	,	0
receptor	receptor	NN	B-NP
cooperative	cooperative	JJ	I-NP
stimulation	stimulation	NN	I-NP
or	or	CC	0
the	the	DT	0
systems	systems	NNS	0
of	of	IN	0
second	second	JJ	0
messengers	messengers	NNS	0
[	[	-LRB-	0
32	32	CD	0
,	,	,	0
33	33	CD	0
]	]	-RRB-	0
,	,	,	0
dietary	dietary	JJ	B-NP
ingredient	ingredient	NN	I-NP
,	,	,	0
e.g.	e.g.	NNP	0
,	,	,	0
retinoid	retinoid	NN	B-NP
[	[	-LRB-	0
34	34	CD	0
]	]	-RRB-	0
,	,	,	0
exercise	exercise	NN	0
[	[	-LRB-	0
35	35	CD	0
,	,	,	0
36	36	CD	0
]	]	-RRB-	0
,	,	,	0
and	and	CC	0
fluid-imposed	fluid-imposed	JJ	0
shear	shear	JJ	0
stress	stress	NN	0
[	[	-LRB-	0
37	37	CD	0
,	,	,	0
38	38	CD	0
,	,	,	0
39	39	CD	0
]	]	-RRB-	0
.	.	.	0
For	For	IN	0
example	example	NN	0
,	,	,	0
endothelial	endothelial	JJ	B-NP
cell	cell	NN	I-NP
are	are	VBP	0
known	known	VBN	0
to	to	TO	0
elongate	elongate	VB	0
and	and	CC	0
reorient	reorient	VB	0
their	their	PRP$	0
cytoskeleton	cytoskeleton	NN	B-NP
in	in	IN	0
the	the	DT	0
direction	direction	NN	0
of	of	IN	0
flow	flow	NN	0
as	as	IN	0
a	a	DT	0
normal	normal	JJ	B-NP
physiological	physiological	JJ	I-NP
response	response	NN	I-NP
to	to	TO	0
prolonged	prolonged	JJ	0
shear	shear	JJ	0
stress	stress	NN	0
[	[	-LRB-	0
29	29	CD	0
]	]	-RRB-	0
.	.	.	0
Results	Results	NNS	0
of	of	IN	0
the	the	DT	0
present	present	JJ	0
studies	studies	NNS	0
show	show	VBP	0
that	that	DT	0
treatment	treatment	NN	0
with	with	IN	0
resveratrol	resveratrol	NN	B-NP
induces	induces	VBZ	0
a	a	DT	0
morphologic	morphologic	JJ	B-NP
change	change	NN	I-NP
from	from	IN	0
a	a	DT	0
stellar	stellar	JJ	B-NP
to	to	TO	0
an	an	DT	0
elongated	elongated	JJ	0
shape	shape	NN	0
(	(	-LRB-	0
Figure	Figure	NNP	0
1	1	CD	0
)	)	-RRB-	0
.	.	.	0
It	It	PRP	0
is	is	VBZ	0
tempting	tempting	VBN	0
to	to	TO	0
speculate	speculate	VB	0
that	that	DT	0
appearance	appearance	NN	0
of	of	IN	0
such	such	JJ	0
cellular	cellular	JJ	B-NP
phenotype	phenotype	NN	I-NP
involves	involves	VBZ	0
formation	formation	NN	0
of	of	IN	0
stress	stress	NN	B-NP
fiber	fiber	NN	I-NP
,	,	,	0
which	which	WDT	0
would	would	MD	0
rearrange	rearrange	VB	0
the	the	DT	0
cytoskeleton	cytoskeleton	NN	B-NP
in	in	IN	0
ways	ways	NNS	0
that	that	WDT	0
facilitate	facilitate	VBP	0
better	better	JJR	0
anchoring	anchoring	NN	0
of	of	IN	0
the	the	DT	0
BPAEC	BPAEC	NNP	B-NP
to	to	TO	0
the	the	DT	0
culture	culture	NN	B-NP
substratum	substratum	NN	I-NP
and	and	CC	0
contribute	contribute	VB	0
to	to	TO	0
the	the	DT	0
bpaec	bpaec	NN	B-NP
ability	ability	NN	I-NP
to	to	TO	0
resist	resist	VB	0
simulated	simulated	JJ	0
arterial	arterial	JJ	B-NP
flow	flow	NN	I-NP
challenge	challenge	NN	I-NP
.	.	.	0
only	only	JJ	B-NP
study	study	NN	I-NP
in	in	IN	0
the	the	DT	0
future	future	NN	0
would	would	MD	0
validate	validate	VB	0
such	such	PDT	0
a	a	DT	0
possibility	possibility	NN	0
.	.	.	0
It	It	PRP	0
is	is	VBZ	0
also	also	RB	0
interesting	interesting	JJ	0
to	to	TO	0
note	note	VB	0
that	that	IN	0
the	the	DT	0
observed	observed	JJ	0
changes	changes	NNS	0
in	in	IN	0
resveratrol-treated	resveratrol-treated	JJ	B-NP
BPAEC	BPAEC	NN	I-NP
are	are	VBP	0
similar	similar	JJ	0
to	to	TO	0
that	that	WDT	0
described	described	VBD	0
for	for	IN	0
EC	EC	NNP	B-NP
subjected	subjected	VBN	0
to	to	TO	0
arterial	arterial	VB	0
shear	shear	NNS	0
.	.	.	0
We	We	PRP	0
propose	propose	VBP	0
that	that	IN	0
this	this	DT	0
could	could	MD	0
represent	represent	VB	0
a	a	DT	0
physiologically-relevant	physiologically-relevant	JJ	0
mechanism	mechanism	NN	0
by	by	IN	0
which	which	WDT	0
resveratrol	resveratrol	VBZ	0
,	,	,	0
as	as	IN	0
a	a	DT	0
polyphenolic	polyphenolic	JJ	B-NP
constituent	constituent	NN	I-NP
of	of	IN	0
red	red	JJ	0
wine	wine	NN	0
,	,	,	0
contributes	contributes	VBZ	0
to	to	TO	0
cardioprotection	cardioprotection	VB	0
by	by	IN	0
inducing	inducing	JJ	0
resistance	resistance	NN	0
to	to	TO	0
potential	potential	JJ	B-NP
damage	damage	NN	I-NP
by	by	IN	0
shearing	shearing	JJ	0
forces	forces	NNS	0
.	.	.	0
The	The	DT	0
mechanism	mechanism	NN	0
underlying	underlying	VBG	0
this	this	DT	0
cytoskeletal	cytoskeletal	JJ	B-NP
rearrangement	rearrangement	JJ	I-NP
due	due	JJ	0
to	to	TO	0
shear	shear	VB	0
stress	stress	NN	0
is	is	VBZ	0
ill-defined	ill-defined	JJ	0
,	,	,	0
but	but	CC	0
it	it	PRP	0
has	has	VBZ	0
been	been	VBN	0
found	found	VBN	0
to	to	TO	0
be	be	VB	0
linked	linked	VBN	0
to	to	TO	0
tyrosine	tyrosine	VB	0
kinase	kinase	JJ	B-NP
activity	activity	NN	I-NP
,	,	,	0
levels	levels	NNS	0
of	of	IN	0
intracellular	intracellular	JJ	B-NP
calcium	calcium	NN	I-NP
,	,	,	0
intact	intact	JJ	0
actin	actin	JJ	B-NP
microfilament	microfilament	NN	I-NP
,	,	,	0
and	and	CC	0
functional	functional	JJ	B-NP
microtubule	microtubule	JJ	I-NP
network	network	NN	I-NP
,	,	,	0
but	but	CC	0
is	is	VBZ	0
independent	independent	JJ	0
of	of	IN	0
protein	protein	NN	B-NP
kinase	kinase	VBD	0
C	C	NNP	0
,	,	,	0
intermediate	intermediate	JJ	0
filaments	filaments	NN	0
,	,	,	0
and	and	CC	0
stretch-	stretch-	JJ	0
and	and	CC	0
shear-activated	shear-activated	JJ	0
mechanosensitive	mechanosensitive	JJ	B-NP
K	K	NNP	I-NP
+channels	+channels	NNP	0
[	[	-LRB-	0
28	28	CD	0
]	]	-RRB-	0
.	.	.	0
We	We	PRP	0
therefore	therefore	RB	0
sought	sought	VBN	0
to	to	TO	0
determine	determine	VB	0
whether	whether	IN	0
a	a	DT	0
similar	similar	JJ	0
mechanism	mechanism	NN	0
could	could	MD	0
account	account	VB	0
for	for	IN	0
the	the	DT	0
resveratrol-mediated	resveratrol-mediated	JJ	B-NP
endothelial	endothelial	JJ	I-NP
shape	shape	NN	I-NP
change	change	NN	I-NP
.	.	.	0
Our	Our	PRP$	0
approach	approach	NN	0
involved	involved	VBN	0
using	using	VBG	0
a	a	DT	0
number	number	NN	0
of	of	IN	0
selective	selective	JJ	B-NP
inhibitor	inhibitor	NN	I-NP
for	for	IN	0
various	various	JJ	0
signaling	signaling	JJ	0
pathway	pathway	NN	0
.	.	.	0
These	These	DT	0
studies	studies	NNS	0
showed	showed	VBD	0
that	that	IN	0
quin2-AM	quin2-AM	NNP	B-NP
(	(	-LRB-	0
[	[	-LRB-	0
Ca	Ca	NNP	B-NP
2+	2+	NNP	0
]	]	-RRB-	0
inhibitor	inhibitor	NN	0
)	)	-RRB-	0
,	,	,	0
added	added	VBD	0
together	together	RB	0
with	with	IN	0
resveratrol	resveratrol	NN	B-NP
,	,	,	0
clearly	clearly	RB	0
abolished	abolished	VBN	0
the	the	DT	0
endothelial	endothelial	JJ	B-NP
cell	cell	NN	I-NP
shape	shape	NN	I-NP
change	change	NN	I-NP
induced	induced	NN	I-NP
by	by	IN	0
the	the	DT	0
polyphenol	polyphenol	NN	B-NP
.	.	.	0
In	In	IN	0
contrast	contrast	NN	0
,	,	,	0
chelerythrine	chelerythrine	NN	B-NP
,	,	,	0
a	a	DT	0
PKC	PKC	NNP	B-NP
inhibitor	inhibitor	NN	0
,	,	,	0
which	which	WDT	0
added	added	VBD	0
alone	alone	RB	0
triggered	triggered	VBD	0
a	a	DT	0
significant	significant	JJ	0
shape	shape	NN	B-NP
change	change	NN	I-NP
in	in	IN	0
BPAEC	BPAEC	NNP	B-NP
,	,	,	0
had	had	VBD	0
no	no	DT	0
effect	effect	NN	0
on	on	IN	0
resveratrol-elicited	resveratrol-elicited	JJ	B-NP
morphological	morphological	JJ	I-NP
change	change	NN	I-NP
(	(	-LRB-	0
Table	Table	NNP	0
1	1	CD	0
)	)	-RRB-	0
.	.	.	0
Analyzed	Analyzed	VBN	0
as	as	IN	0
a	a	DT	0
whole	whole	NN	0
,	,	,	0
these	these	DT	0
experiments	experiments	NNS	0
suggest	suggest	VBP	0
that	that	IN	0
the	the	DT	0
change	change	NN	0
in	in	IN	0
cellular	cellular	JJ	B-NP
phenotype	phenotype	NN	I-NP
,	,	,	0
as	as	IN	0
a	a	DT	0
consequence	consequence	NN	0
of	of	IN	0
resveratrol	resveratrol	NN	B-NP
:	:	:	0
EC	EC	NNP	B-NP
interaction	interaction	NN	I-NP
,	,	,	0
is	is	VBZ	0
dependent	dependent	JJ	0
on	on	IN	0
Ca	Ca	NNP	B-NP
2+	2+	NNP	0
,	,	,	0
tyrosine	tyrosine	JJ	B-NP
kinas	kinas	NNP	I-NP
,	,	,	0
and	and	CC	0
intact	intact	JJ	0
actin	actin	JJ	B-NP
microfilament	microfilament	NN	I-NP
and	and	CC	0
microtubule	microtubule	NN	B-NP
.	.	.	0
These	These	DT	0
results	results	NNS	0
also	also	RB	0
raise	raise	VB	0
the	the	DT	0
possibility	possibility	NN	0
that	that	IN	0
there	there	EX	0
is	is	VBZ	0
cellular	cellular	JJ	B-NP
heterogeneity	heterogeneity	NN	I-NP
within	within	IN	0
endothelial	endothelial	JJ	B-NP
cell	cell	NN	I-NP
used	used	VBN	0
in	in	IN	0
the	the	DT	0
studies	studies	NNS	0
,	,	,	0
based	based	VBN	0
on	on	IN	0
the	the	DT	0
fact	fact	NN	0
that	that	IN	0
a	a	DT	0
subset	subset	NN	B-NP
displayed	displayed	VBD	0
exquisite	exquisite	JJ	0
sensitivity	sensitivity	NN	0
to	to	TO	0
chelerythrine	chelerythrine	VB	0
.	.	.	0
Overall	Overall	RB	0
,	,	,	0
these	these	DT	0
results	results	NNS	0
support	support	VBP	0
the	the	DT	0
notion	notion	NN	0
that	that	IN	0
resveratrol	resveratrol	NN	B-NP
and	and	CC	0
shear	shear	JJ	0
stress	stress	NN	0
induce	induce	VB	0
elongation	elongation	VBN	0
of	of	IN	0
the	the	DT	0
EC	EC	NNP	B-NP
cytoskeleton	cytoskeleton	NN	I-NP
via	via	IN	0
an	an	DT	0
overlapping	overlapping	JJ	0
outside-in	outside-in	JJ	0
signaling	signaling	JJ	0
mechanism	mechanism	NN	0
.	.	.	0
Prolonged	Prolonged	JJ	0
shear	shear	NNS	0
stress	stress	VBP	0
leading	leading	VBG	0
to	to	TO	0
mechanotransduction	mechanotransduction	VB	0
signaling	signaling	NN	0
has	has	VBZ	0
been	been	VBN	0
shown	shown	VBN	0
to	to	TO	0
activate	activate	VB	0
the	the	DT	0
MAP	MAP	NNP	0
kinase	kinase	VBD	0
pathway	pathway	VBN	0
in	in	IN	0
EC	EC	NNP	B-NP
.	.	.	0
erk1	erk1	NN	B-NP
activation	activation	NN	I-NP
and	and	CC	0
ERK2	ERK2	NNP	B-NP
,	,	,	0
the	the	DT	0
major	major	JJ	0
components	components	NNS	0
of	of	IN	0
the	the	DT	0
MAPK	MAPK	NNP	B-NP
pathway	pathway	NN	I-NP
,	,	,	0
presumably	presumably	RB	0
induces	induces	VBZ	0
shear-specific	shear-specific	JJ	B-NP
transcription	transcription	JJ	I-NP
factor	factor	NN	I-NP
,	,	,	0
such	such	JJ	0
as	as	IN	0
c-fos	c-fos	NNP	B-NP
/	/	NNP	I-NP
c-jun	c-jun	NNP	I-NP
and	and	CC	0
NFκB	NFκB	JJ	0
,	,	,	0
ultimately	ultimately	RB	0
leading	leading	VBG	0
to	to	TO	0
changes	changes	NNS	0
in	in	IN	0
gene	gene	NN	B-NP
expression	expression	NN	I-NP
[	[	-LRB-	0
30	30	CD	0
,	,	,	0
31	31	CD	0
]	]	-RRB-	0
.	.	.	0
Western	Western	JJ	0
blot	blot	JJ	0
analysis	analysis	NN	0
of	of	IN	0
control	control	NN	0
and	and	CC	0
25	25	CD	0
μM	μM	JJ	0
and	and	CC	0
100	100	CD	0
μM	μM	JJ	B-NP
resveratrol-treated	resveratrol-treated	JJ	I-NP
BPAEC	BPAEC	NNP	I-NP
showed	showed	VBD	0
that	that	IN	0
there	there	EX	0
was	was	VBD	0
no	no	DT	0
increase	increase	NN	0
in	in	IN	0
active	active	JJ	0
extracellular	extracellular	NN	B-NP
signal	signal	JJ	I-NP
regulated	regulated	VBN	I-NP
kinase	kinase	NN	I-NP
1	1	CD	0
/	/	CD	0
2	2	CD	0
at	at	IN	0
the	the	DT	0
6	6	CD	0
h	h	NNS	0
and	and	CC	0
2	2	CD	0
day	day	NN	0
time	time	NN	0
points	points	NNS	0
.	.	.	0
Rather	Rather	RB	0
,	,	,	0
the	the	DT	0
decline	decline	NN	0
in	in	IN	0
activated	activated	JJ	0
extracellular	extracellular	NN	B-NP
signal	signal	JJ	I-NP
regulated	regulated	VBN	I-NP
kinase	kinase	NN	I-NP
1	1	CD	0
/	/	CD	0
2	2	CD	0
seen	seen	VBN	0
from	from	IN	0
days	days	NNS	0
2	2	CD	0
to	to	TO	0
4	4	CD	0
of	of	IN	0
control	control	NN	B-NP
cell	cell	NN	I-NP
,	,	,	0
was	was	VBD	0
effectively	effectively	RB	0
suppressed	suppressed	VBN	0
by	by	IN	0
resveratrol	resveratrol	NN	B-NP
,	,	,	0
suggesting	suggesting	VBG	0
that	that	IN	0
the	the	DT	0
polyphenol	polyphenol	NN	B-NP
may	may	MD	0
act	act	VB	0
by	by	IN	0
affecting	affecting	VBG	0
the	the	DT	0
stability	stability	NN	0
of	of	IN	0
active	active	JJ	0
ERK1	ERK1	CD	B-NP
/	/	CD	0
2	2	CD	0
(	(	-LRB-	0
Figure	Figure	NNP	0
6	6	CD	0
)	)	-RRB-	0
.	.	.	0
This	This	DT	0
may	may	MD	0
involve	involve	VB	0
mapk	mapk	NN	B-NP
phosphatase-1	phosphatase-1	NNP	I-NP
modulation	modulation	VBN	I-NP
(	(	-LRB-	0
MKP-1	MKP-1	NNP	B-NP
)	)	-RRB-	0
,	,	,	0
a	a	DT	0
member	member	NN	0
of	of	IN	0
the	the	DT	0
immediate-early	immediate-early	JJ	B-NP
response	response	NN	I-NP
gene	gene	NN	I-NP
product	product	NN	I-NP
functioning	functioning	VBG	0
as	as	IN	0
a	a	DT	0
dual	dual	JJ	B-NP
specificity	specificity	JJ	I-NP
phosphase	phosphase	NN	I-NP
to	to	TO	0
reverse	reverse	VB	0
mitogen	mitogen	NN	B-NP
activated	activated	VBN	I-NP
protein	protein	NN	I-NP
kinase	kinase	NN	I-NP
[	[	-LRB-	0
40	40	CD	0
,	,	,	0
41	41	CD	0
,	,	,	0
42	42	CD	0
,	,	,	0
43	43	CD	0
,	,	,	0
44	44	CD	0
]	]	-RRB-	0
,	,	,	0
by	by	IN	0
resveratrol	resveratrol	NN	B-NP
.	.	.	0
Previously	Previously	RB	0
,	,	,	0
it	it	PRP	0
has	has	VBZ	0
been	been	VBN	0
reported	reported	VBN	0
that	that	IN	0
mapk	mapk	NN	B-NP
phosphatase	phosphatase	NN	I-NP
1	1	NN	I-NP
is	is	VBZ	0
rapidly	rapidly	RB	0
induced	induced	VBN	0
in	in	IN	0
rat	rat	NN	B-NP
carotid	carotid	NN	I-NP
arterial	arterial	JJ	I-NP
wall	wall	NN	I-NP
following	following	FW	0
balloon	balloon	NN	B-NP
catheter	catheter	NN	I-NP
injury	injury	NN	I-NP
[	[	-LRB-	0
45	45	CD	0
]	]	-RRB-	0
.	.	.	0
Since	Since	IN	0
no	no	DT	0
noticeable	noticeable	JJ	0
change	change	NN	0
in	in	IN	0
active	active	JJ	0
ERK1	ERK1	CD	B-NP
/	/	CD	0
2	2	CD	0
occurred	occurred	VBD	0
at	at	IN	0
the	the	DT	0
6	6	CD	0
h	h	NNS	0
or	or	CC	0
2	2	CD	0
day	day	NN	0
time	time	NN	0
points	points	NNS	0
,	,	,	0
where	where	WRB	0
morphological	morphological	JJ	B-NP
change	change	NN	I-NP
clearly	clearly	RB	0
became	became	VBD	0
visible	visible	JJ	0
,	,	,	0
following	following	VBG	0
treatment	treatment	NN	0
with	with	IN	0
resveratrol	resveratrol	NN	B-NP
,	,	,	0
it	it	PRP	0
seems	seems	VBZ	0
unlikely	unlikely	JJ	0
that	that	IN	0
the	the	DT	0
mitogen	mitogen	NN	B-NP
activated	activated	VBN	I-NP
protein	protein	NN	I-NP
kinase	kinase	NN	I-NP
activation	activation	NN	I-NP
is	is	VBZ	0
directly	directly	RB	0
linked	linked	VBN	0
to	to	TO	0
the	the	DT	0
observed	observed	JJ	0
morphologic	morphologic	JJ	B-NP
change	change	NN	I-NP
.	.	.	0
Responses	Responses	NNS	0
of	of	IN	0
cultured	cultured	JJ	0
endothelial	endothelial	JJ	B-NP
cell	cell	NN	I-NP
to	to	TO	0
arterial	arterial	VB	0
shear	shear	NNS	0
stress	stress	VBP	0
Another	Another	DT	0
significant	significant	JJ	0
contribution	contribution	NN	B-NP
of	of	IN	0
the	the	DT	0
present	present	JJ	0
research	research	NN	0
is	is	VBZ	0
the	the	DT	0
demonstration	demonstration	NN	B-NP
that	that	WDT	0
resveratrol	resveratrol	VBZ	0
promoted	promoted	VBN	0
a	a	DT	0
greater	greater	JJR	0
adherence	adherence	NN	0
of	of	IN	0
BPAEC	BPAEC	NNP	B-NP
to	to	TO	0
the	the	DT	0
cultured	cultured	JJ	0
vehicle	vehicle	NN	B-NP
in	in	IN	0
vitro	vitro	NN	B-NP
.	.	.	0
In	In	IN	0
vivo	vivo	NN	B-NP
,	,	,	0
such	such	PDT	0
a	a	DT	0
cellular	cellular	JJ	B-NP
property	property	NN	I-NP
could	could	MD	0
make	make	VB	0
endothelial	endothelial	JJ	B-NP
cell	cell	NN	I-NP
less	less	RBR	0
likely	likely	JJ	0
to	to	TO	0
dislodge	dislodge	VB	0
to	to	TO	0
become	become	VB	0
part	part	NN	0
of	of	IN	0
a	a	DT	0
growing	growing	VBG	0
thrombotic	thrombotic	JJ	B-NP
plug	plug	NN	I-NP
.	.	.	0
Restricted	Restricted	JJ	B-NP
detachment	detachment	NN	I-NP
could	could	MD	0
also	also	RB	0
imply	imply	VB	0
that	that	IN	0
there	there	EX	0
is	is	VBZ	0
less	less	JJR	0
endothelial	endothelial	JJ	B-NP
cell	cell	NN	I-NP
monolayer	monolayer	NN	I-NP
degeneration	degeneration	NN	I-NP
,	,	,	0
which	which	WDT	0
,	,	,	0
in	in	IN	0
turn	turn	NN	0
,	,	,	0
would	would	MD	0
reduce	reduce	VB	0
the	the	DT	0
exposure	exposure	NN	0
of	of	IN	0
the	the	DT	0
underlying	underlying	JJ	0
subendothelial	subendothelial	JJ	B-NP
matrix	matrix	JJ	I-NP
component	component	JJ	I-NP
,	,	,	0
thereby	thereby	RB	0
making	making	VBG	0
platelet	platelet	JJ	B-NP
adhesion	adhesion	NN	I-NP
and	and	CC	0
aggregation	aggregation	NN	B-NP
less	less	RBR	0
likely	likely	JJ	0
.	.	.	0
The	The	DT	0
mechanism	mechanism	NN	B-NP
responsible	responsible	JJ	0
for	for	IN	0
the	the	DT	0
resveratrol-induced	resveratrol-induced	JJ	B-NP
cellular	cellular	JJ	I-NP
property	property	NN	I-NP
remain	remain	VBP	0
to	to	TO	0
be	be	VB	0
further	further	RB	0
investigated	investigated	VBN	0
.	.	.	0
One	One	CD	0
possibility	possibility	NN	0
centers	centers	NNS	0
on	on	IN	0
modulation	modulation	NN	B-NP
of	of	IN	0
the	the	DT	0
number	number	NN	0
of	of	IN	0
focal	focal	JJ	B-NP
contact	contact	NN	I-NP
adhesion	adhesion	NN	I-NP
site	site	NN	I-NP
,	,	,	0
and	and	CC	0
/	/	NNP	0
or	or	CC	0
the	the	DT	0
effective	effective	JJ	0
focal	focal	JJ	B-NP
contact	contact	NN	I-NP
redistribution	redistribution	NN	I-NP
,	,	,	0
as	as	RB	0
well	well	RB	0
as	as	IN	0
the	the	DT	0
increased	increased	JJ	0
production	production	NN	0
of	of	IN	0
the	the	DT	0
EC-specific	EC-specific	JJ	B-NP
integrin	integrin	JJ	I-NP
complex	complex	NN	I-NP
,	,	,	0
by	by	IN	0
resveratrol	resveratrol	NN	B-NP
,	,	,	0
all	all	DT	0
of	of	IN	0
which	which	WDT	0
could	could	MD	0
contribute	contribute	VB	0
to	to	TO	0
the	the	DT	0
cardioprotective	cardioprotective	JJ	B-NP
mechanism	mechanism	NN	I-NP
of	of	IN	0
this	this	DT	0
polyphenol	polyphenol	NN	B-NP
.	.	.	0
However	However	RB	0
,	,	,	0
it	it	PRP	0
should	should	MD	0
be	be	VB	0
emphasized	emphasized	VBN	0
that	that	IN	0
these	these	DT	0
experiments	experiments	NNS	0
involved	involved	VBN	0
growing	growing	VBG	B-NP
EC	EC	NNP	I-NP
on	on	IN	0
plastic	plastic	NN	0
,	,	,	0
not	not	RB	0
on	on	IN	0
layers	layers	NNS	0
of	of	IN	0
subendothelial	subendothelial	JJ	B-NP
matrix	matrix	JJ	I-NP
component	component	JJ	I-NP
such	such	JJ	0
as	as	IN	0
collagen	collagen	NN	B-NP
or	or	CC	0
fibrinogen	fibrinogen	NN	B-NP
.	.	.	0
The	The	DT	0
latter	latter	JJ	0
experimental	experimental	JJ	B-NP
format	format	NN	I-NP
simulating	simulating	VBD	0
a	a	DT	0
more	more	RBR	0
physiologically	physiologically	JJ	B-NP
relevant	relevant	JJ	I-NP
subendothelial	subendothelial	JJ	I-NP
matrix	matrix	NN	I-NP
may	may	MD	0
yield	yield	VB	0
vastly	vastly	RB	0
different	different	JJ	0
results	results	NNS	0
.	.	.	0
These	These	DT	0
possibilities	possibilities	NNS	0
warrant	warrant	VBP	0
further	further	JJ	0
investigation	investigation	NN	B-NP
.	.	.	0
enzyme	enzyme	NN	B-NP
nitric	nitric	JJ	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
oxide	oxide	NN	I-NP
synthase	synthase	NN	I-NP
induction	induction	NN	I-NP
and	and	CC	0
ec	ec	NN	B-NP
growth	growth	NN	I-NP
modulation	modulation	NN	I-NP
by	by	IN	0
resveratrol	resveratrol	VBG	0
The	The	DT	0
endothelial	endothelial	JJ	B-NP
cell	cell	NN	I-NP
lining	lining	NN	I-NP
of	of	IN	0
the	the	DT	0
blood	blood	NN	0
vessel	vessel	NN	0
is	is	VBZ	0
extremely	extremely	RB	0
sensitive	sensitive	JJ	0
to	to	TO	0
damage	damage	NN	0
from	from	IN	0
reactive	reactive	JJ	B-NP
oxygen	oxygen	NN	I-NP
specie	specie	NN	I-NP
(	(	-LRB-	0
ROS	ROS	NNP	B-NP
)	)	-RRB-	0
,	,	,	0
the	the	DT	0
results	results	NNS	0
of	of	IN	0
which	which	WDT	0
are	are	VBP	0
losses	losses	NNS	0
of	of	IN	0
both	both	DT	0
microvascular	microvascular	JJ	B-NP
metabolic	metabolic	JJ	I-NP
function	function	NN	I-NP
and	and	CC	0
barrier	barrier	NN	B-NP
property	property	NN	I-NP
[	[	-LRB-	0
46	46	CD	0
]	]	-RRB-	0
.	.	.	0
To	To	TO	0
minimize	minimize	VB	0
such	such	JJ	0
oxidant	oxidant	JJ	B-NP
damage	damage	NN	I-NP
,	,	,	0
cells	cells	NNS	0
rely	rely	VBP	0
on	on	IN	0
the	the	DT	0
production	production	NN	0
of	of	IN	0
nitric	nitric	JJ	B-NP
oxide	oxide	NN	I-NP
(	(	-LRB-	0
NO	NO	UH	B-NP
)	)	-RRB-	0
by	by	IN	0
the	the	DT	0
nitric	nitric	JJ	B-NP
oxide	oxide	NN	I-NP
synthase	synthase	NN	I-NP
enzyme	enzyme	NN	I-NP
(	(	-LRB-	0
eNOS	eNOS	NNP	B-NP
)	)	-RRB-	0
.	.	.	0
biological	biological	JJ	B-NP
function	function	NN	I-NP
attributed	attributed	VBD	0
to	to	TO	0
NO	NO	RB	0
include	include	VB	0
vasodilation	vasodilation	NN	B-NP
[	[	-LRB-	0
47	47	CD	0
]	]	-RRB-	0
,	,	,	0
inhibition	inhibition	VBG	0
of	of	IN	0
platelet	platelet	JJ	B-NP
adhesion	adhesion	NN	I-NP
and	and	CC	0
aggregation	aggregation	NN	B-NP
[	[	-LRB-	0
48	48	CD	0
]	]	-RRB-	0
,	,	,	0
reduction	reduction	NN	0
of	of	IN	0
expression	expression	NN	0
of	of	IN	0
adhesion	adhesion	JJ	B-NP
molecule	molecule	NN	I-NP
and	and	CC	0
chemokine	chemokine	NN	B-NP
[	[	-LRB-	0
49	49	CD	0
,	,	,	0
50	50	CD	0
,	,	,	0
51	51	CD	0
,	,	,	0
52	52	CD	0
]	]	-RRB-	0
,	,	,	0
and	and	CC	0
suppression	suppression	NN	0
of	of	IN	0
cell	cell	NN	B-NP
growth	growth	NN	I-NP
and	and	CC	0
migration	migration	NNS	0
[	[	-LRB-	0
53	53	CD	0
,	,	,	0
54	54	CD	0
]	]	-RRB-	0
.	.	.	0
Therefore	Therefore	RB	0
,	,	,	0
we	we	PRP	0
investigated	investigated	VBD	0
whether	whether	IN	0
resveratrol	resveratrol	JJ	B-NP
treatment	treatment	NN	I-NP
could	could	MD	0
lead	lead	VB	0
to	to	TO	0
increased	increased	VB	B-NP
eNOS	eNOS	JJ	I-NP
expression	expression	NN	I-NP
in	in	IN	0
endothelial	endothelial	JJ	B-NP
cell	cell	NN	I-NP
.	.	.	0
We	We	PRP	0
determined	determined	VBD	0
that	that	DT	0
resveratrol	resveratrol	JJ	B-NP
treatment	treatment	NN	I-NP
did	did	VBD	0
induce	induce	VB	0
eNOS	eNOS	JJ	B-NP
expression	expression	NN	I-NP
at	at	IN	0
all	all	DT	0
time	time	NN	B-NP
point	point	NN	I-NP
tested	tested	VBD	0
(	(	-LRB-	0
6	6	CD	0
h	h	NN	0
,	,	,	0
2	2	CD	0
days	days	NNS	0
,	,	,	0
and	and	CC	0
4	4	CD	0
days	days	NNS	0
)	)	-RRB-	0
.	.	.	0
These	These	DT	0
results	results	NNS	0
agreed	agreed	VBD	0
with	with	IN	0
a	a	DT	0
previous	previous	JJ	0
report	report	NN	0
from	from	IN	0
this	this	DT	0
laboratory	laboratory	NN	0
[	[	-LRB-	0
21	21	CD	0
]	]	-RRB-	0
.	.	.	0
The	The	DT	0
enzyme	enzyme	NN	B-NP
nitric	nitric	JJ	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
oxide	oxide	NN	I-NP
synthase	synthase	NN	I-NP
peak	peak	NN	I-NP
expression	expression	NN	I-NP
occurred	occurred	VBD	0
at	at	IN	0
2	2	CD	0
days	days	NNS	0
in	in	IN	0
100	100	CD	0
μm	μm	NN	B-NP
resveratrol-treated	resveratrol-treated	JJ	I-NP
cell	cell	NN	I-NP
.	.	.	0
These	These	DT	0
findings	findings	NNS	0
could	could	MD	0
mean	mean	VB	0
that	that	DT	0
dietary	dietary	JJ	B-NP
resveratrol	resveratrol	NN	I-NP
is	is	VBZ	0
capable	capable	JJ	0
of	of	IN	0
providing	providing	VBG	0
a	a	DT	0
gradual	gradual	JJ	0
yet	yet	RB	0
sustained	sustained	VBN	B-NP
increase	increase	NN	I-NP
in	in	IN	0
NO	NO	RB	0
.	.	.	0
The	The	DT	0
ability	ability	NN	B-NP
of	of	IN	0
resveratrol	resveratrol	VBG	0
to	to	TO	0
induce	induce	VB	0
S	S	NNP	B-NP
/	/	NNP	I-NP
G	G	NNP	I-NP
2	2	CD	0
growth	growth	NN	B-NP
arrest	arrest	NN	I-NP
[	[	-LRB-	0
20	20	CD	0
,	,	,	0
21	21	CD	0
]	]	-RRB-	0
suggests	suggests	VBZ	0
an	an	DT	0
additional	additional	JJ	0
mechanism	mechanism	NN	0
for	for	IN	0
cells	cells	NNS	0
to	to	TO	0
rapidly	rapidly	RB	0
and	and	CC	0
efficiently	efficiently	RB	0
repair	repair	VB	0
any	any	DT	0
endothelial	endothelial	JJ	B-NP
cell	cell	NN	I-NP
damage	damage	NN	I-NP
.	.	.	0
Overall	Overall	RB	0
,	,	,	0
the	the	DT	0
resveratrol	resveratrol	NNS	B-NP
collective	collective	JJ	I-NP
effect	effect	NN	I-NP
would	would	MD	0
be	be	VB	0
to	to	TO	0
decrease	decrease	VB	0
endothelial	endothelial	JJ	B-NP
injury	injury	NN	I-NP
and	and	CC	0
exposure	exposure	NN	0
of	of	IN	0
the	the	DT	0
subendothelial	subendothelial	JJ	B-NP
matrix	matrix	NN	I-NP
,	,	,	0
which	which	WDT	0
would	would	MD	0
lessen	lessen	VB	0
the	the	DT	0
probability	probability	NN	B-NP
of	of	IN	0
formation	formation	NN	0
of	of	IN	0
atherosclerotic	atherosclerotic	JJ	B-NP
plaque	plaque	NN	I-NP
and	and	CC	0
the	the	DT	0
development	development	NN	0
of	of	IN	0
coronary	coronary	JJ	B-NP
heart	heart	NN	I-NP
disease	disease	NN	I-NP
[	[	-LRB-	0
53	53	CD	0
,	,	,	0
54	54	CD	0
,	,	,	0
55	55	CD	0
]	]	-RRB-	0
.	.	.	0
Conclusions	Conclusions	VBG	0
Our	Our	PRP$	0
studies	studies	NNS	0
suggest	suggest	VBP	0
that	that	IN	0
resveratrol	resveratrol	JJ	0
interacts	interacts	NN	0
with	with	IN	0
endothelial	endothelial	JJ	B-NP
cell	cell	NN	I-NP
in	in	IN	0
vitro	vitro	VBG	B-NP
to	to	TO	0
elicit	elicit	VB	0
morphological	morphological	NNS	0
and	and	CC	0
functional	functional	JJ	B-NP
change	change	NN	I-NP
.	.	.	0
Specifically	Specifically	RB	0
,	,	,	0
resveratrol	resveratrol	VBD	0
induced	induced	VBN	0
an	an	DT	0
elongated	elongated	JJ	0
shape	shape	NN	0
,	,	,	0
interspersed	interspersed	VBN	0
with	with	IN	0
long	long	JJ	0
,	,	,	0
tortuous	tortuous	JJ	B-NP
projection	projection	NN	I-NP
,	,	,	0
in	in	IN	0
cultured	cultured	JJ	0
BPAEC	BPAEC	NNP	B-NP
.	.	.	0
Treated	Treated	JJ	0
cells	cells	NNS	0
resisted	resisted	VBD	B-NP
detachment	detachment	VBN	I-NP
from	from	IN	0
the	the	DT	0
plastic	plastic	JJ	B-NP
coverslip	coverslip	NN	I-NP
under	under	IN	0
simulated	simulated	JJ	0
arterial	arterial	JJ	0
shear	shear	JJ	0
stress	stress	NN	B-NP
condition	condition	NN	I-NP
.	.	.	0
These	These	DT	0
results	results	NNS	0
,	,	,	0
combined	combined	VBN	0
with	with	IN	0
data	data	NNS	0
from	from	IN	0
our	our	PRP$	0
previous	previous	JJ	0
studies	studies	NNS	0
,	,	,	0
provide	provide	VB	0
additional	additional	JJ	0
support	support	NN	0
for	for	IN	0
the	the	DT	0
notion	notion	NN	0
that	that	IN	0
resveratrol	resveratrol	JJ	B-NP
act	act	NN	I-NP
as	as	IN	0
an	an	DT	0
anti-atherosclerotic	anti-atherosclerotic	JJ	B-NP
agent	agent	NN	I-NP
.	.	.	0
Whether	Whether	IN	0
these	these	DT	0
findings	findings	NNS	0
can	can	MD	0
be	be	VB	0
extrapolated	extrapolated	VBN	0
to	to	TO	0
humans	humans	NNS	0
require	require	VBP	0
further	further	JJ	0
study	study	NN	0
.	.	.	0
Materials	Materials	NNS	0
and	and	CC	0
Methods	Methods	NNP	0
Cell	Cell	NNP	0
culture	culture	NN	0
and	and	CC	0
treatment	treatment	NN	0
with	with	IN	0
resveratrol	resveratrol	VBG	0
The	The	DT	0
BPAEC	BPAEC	NNP	B-NP
isolated	isolated	VBD	0
from	from	IN	0
the	the	DT	0
distal	distal	JJ	B-NP
main	main	JJ	I-NP
intrapulmonary	intrapulmonary	JJ	I-NP
artery	artery	NN	I-NP
of	of	IN	0
calf	calf	JJ	0
lungs	lungs	NNS	0
were	were	VBD	0
cultured	cultured	VBN	0
in	in	IN	0
minimal	minimal	JJ	B-NP
essential	essential	JJ	I-NP
medium	medium	NN	I-NP
(	(	-LRB-	0
MEM	MEM	NNP	B-NP
)	)	-RRB-	0
supplemented	supplemented	NN	0
with	with	IN	0
15	15	CD	0
%	%	NN	0
fetal	fetal	JJ	B-NP
bovine	bovine	JJ	I-NP
serum	serum	NN	I-NP
and	and	CC	0
containing	containing	VBG	B-NP
D-valine	D-valine	JJ	I-NP
as	as	IN	0
previously	previously	RB	0
described	described	VBN	0
[	[	-LRB-	0
56	56	CD	0
]	]	-RRB-	0
.	.	.	0
plastic	plastic	JJ	B-NP
coverslip	coverslip	NN	I-NP
on	on	IN	0
which	which	WDT	0
the	the	DT	0
cells	cells	NNS	0
were	were	VBD	0
cultured	cultured	RB	0
were	were	VBD	0
sterilized	sterilized	VBN	0
by	by	IN	0
washing	washing	VBG	0
in	in	IN	0
ethanol	ethanol	NN	B-NP
,	,	,	0
followed	followed	VBN	0
by	by	IN	0
rinsing	rinsing	CD	0
three	three	CD	0
times	times	NNS	0
in	in	IN	0
minimal	minimal	JJ	B-NP
essential	essential	JJ	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
medium	medium	JJ	I-NP
and	and	CC	0
15	15	CD	0
min	min	JJ	B-NP
exposure	exposure	NN	I-NP
to	to	TO	0
UV	UV	NNP	B-NP
radiation	radiation	NN	I-NP
.	.	.	0
The	The	DT	0
coverslip	coverslip	NN	B-NP
were	were	VBD	0
placed	placed	VBN	0
in	in	IN	0
6-well	6-well	CD	0
tissue	tissue	NN	0
culture	culture	NN	0
plates	plates	NN	0
,	,	,	0
and	and	CC	0
2	2	CD	0
ml	ml	NN	0
of	of	IN	0
the	the	DT	0
cells	cells	NNS	0
,	,	,	0
at	at	IN	0
an	an	DT	0
initial	initial	JJ	0
density	density	NN	0
of	of	IN	0
1	1	CD	0
×	×	CD	0
10	10	CD	0
5cells	5cells	CD	0
/	/	CD	0
ml	ml	NN	0
,	,	,	0
were	were	VBD	0
added	added	VBN	0
to	to	TO	0
each	each	DT	0
of	of	IN	0
the	the	DT	0
wells	wells	NNS	0
.	.	.	0
Twenty-four	Twenty-four	CD	0
h	h	NN	0
after	after	IN	0
seeding	seeding	NN	0
,	,	,	0
the	the	DT	0
coverslip	coverslip	NN	B-NP
were	were	VBD	0
treated	treated	VBN	0
with	with	IN	0
0,10	0,10	NNP	0
,	,	,	0
25	25	CD	0
,	,	,	0
50	50	CD	0
,	,	,	0
and	and	CC	0
100	100	CD	0
μM	μM	JJ	B-NP
resveratrol	resveratrol	NN	I-NP
and	and	CC	0
maintained	maintained	VBN	0
for	for	IN	0
2	2	CD	0
days	days	NNS	0
at	at	IN	0
37°C	37°C	CD	0
until	until	IN	0
they	they	PRP	0
were	were	VBD	0
fixed	fixed	VBN	B-NP
and	and	CC	0
stained	stained	NN	0
for	for	IN	0
confocal	confocal	JJ	B-NP
microscopy	microscopy	NN	I-NP
.	.	.	0
Preparation	Preparation	NN	B-NP
and	and	CC	0
staining	staining	NN	0
of	of	IN	0
slides	slides	FW	0
coverslip	coverslip	NN	B-NP
containing	containing	FW	0
adhered	adhered	VBN	B-NP
BPAEC	BPAEC	NNP	I-NP
were	were	VBD	0
washed	washed	VBN	0
for	for	IN	0
5	5	CD	0
min	min	NN	B-NP
in	in	IN	0
tb	tb	NN	B-NP
,	,	,	0
fixed	fixed	VBN	B-NP
with	with	IN	0
5	5	CD	0
%	%	NN	0
glutaraldehyde	glutaraldehyde	NN	B-NP
in	in	IN	0
0.1	0.1	CD	0
M	M	NNP	0
cacodylata	cacodylata	NN	B-NP
(	(	-LRB-	0
pH	pH	NNP	B-NP
7.4	7.4	CD	0
)	)	-RRB-	0
for	for	IN	0
15	15	CD	0
min	min	NN	B-NP
,	,	,	0
washed	washed	VBD	0
again	again	RB	0
for	for	IN	0
5	5	CD	0
min	min	NN	B-NP
in	in	IN	0
tb	tb	NN	B-NP
,	,	,	0
then	then	RB	0
stored	stored	VBN	0
in	in	IN	0
0.1	0.1	CD	0
M	M	NNP	0
cacodylate	cacodylate	VBD	0
/	/	CD	0
7	7	CD	0
%	%	NN	0
sucrose	sucrose	NN	B-NP
at	at	IN	0
4°C	4°C	CD	0
until	until	IN	0
staining	staining	NN	0
.	.	.	0
Cells	Cells	NNS	0
were	were	VBD	0
permeabilized	permeabilized	VBN	0
with	with	IN	0
0.1	0.1	CD	0
%	%	NN	0
Triton	Triton	NNP	B-NP
X-100	X-100	NNP	I-NP
/	/	NNP	0
tb	tb	NN	B-NP
for	for	IN	0
3	3	CD	0
min	min	NN	B-NP
,	,	,	0
washed	washed	VBD	0
twice	twice	RB	0
with	with	IN	0
tb	tb	NN	B-NP
,	,	,	0
blocked	blocked	VBD	0
twice	twice	RB	0
for	for	IN	0
3	3	CD	0
min	min	NN	B-NP
with	with	IN	0
0.1	0.1	CD	0
%	%	NN	0
bovina	bovina	NN	B-NP
serum	serum	VBP	I-NP
albumin	albumin	VBN	0
in	in	IN	0
tb	tb	NN	B-NP
,	,	,	0
and	and	CC	0
incubated	incubated	NN	0
with	with	IN	0
rhodamine-conjugated	rhodamine-conjugated	JJ	B-NP
phalloidin	phalloidin	NN	I-NP
for	for	IN	0
20	20	CD	0
min	min	NN	B-NP
.	.	.	0
Routinely	Routinely	RB	0
,	,	,	0
5	5	CD	0
rhodamine-phalloidin	rhodamine-phalloidin	NNP	B-NP
μl	μl	NN	I-NP
,	,	,	0
dissolved	dissolved	VBN	0
in	in	IN	0
200	200	CD	0
μl	μl	JJ	B-NP
tb	tb	NN	I-NP
,	,	,	0
was	was	VBD	0
used	used	VBN	0
for	for	IN	0
each	each	DT	0
coverslip	coverslip	JJ	B-NP
stained	stained	NN	I-NP
.	.	.	0
The	The	DT	0
coverslip	coverslip	NN	B-NP
were	were	VBD	0
wash	wash	VBN	0
with	with	IN	0
0.1	0.1	CD	0
%	%	NN	0
bsa/tb	bsa/tb	NN	B-NP
for	for	IN	0
3	3	CD	0
min	min	NN	B-NP
,	,	,	0
then	then	RB	0
mounted	mounted	VBN	0
in	in	IN	0
an	an	DT	0
inverted	inverted	JJ	0
position	position	NN	0
onto	onto	IN	0
TBS-containing	TBS-containing	JJ	0
beveled	beveled	JJ	0
glass	glass	NN	0
slides	slides	NNS	0
and	and	CC	0
sealed	sealed	VBN	0
with	with	IN	0
clear	clear	JJ	0
nail	nail	NN	0
polish	polish	NN	0
.	.	.	0
Perfusion	Perfusion	VBG	0
A	A	DT	0
parallel	parallel	JJ	0
plate	plate	NN	B-NP
perfusion	perfusion	NN	I-NP
chamber	chamber	NN	I-NP
as	as	IN	0
described	described	VBN	0
previously	previously	RB	0
[	[	-LRB-	0
57	57	CD	0
]	]	-RRB-	0
was	was	VBD	0
used	used	VBN	0
to	to	TO	0
generate	generate	VB	0
simulated	simulated	JJ	0
arterial	arterial	JJ	B-NP
flow	flow	NN	I-NP
condition	condition	NN	I-NP
.	.	.	0
The	The	DT	0
chamber	chamber	NN	0
consisted	consisted	VBD	0
of	of	IN	0
three	three	CD	0
pieces	pieces	NNS	0
:	:	:	0
two	two	CD	0
rectangular	rectangular	CD	B-NP
slab	slab	NN	I-NP
and	and	CC	0
a	a	DT	0
central	central	JJ	0
knob	knob	NN	B-NP
with	with	IN	0
a	a	DT	0
depression	depression	NN	0
that	that	WDT	0
fits	fits	VBZ	0
18	18	CD	0
by	by	IN	0
21	21	CD	0
mm	mm	CD	B-NP
coverslip	coverslip	NN	I-NP
.	.	.	0
The	The	DT	0
depression	depression	NN	0
containing	containing	VBG	0
the	the	DT	0
coverslip	coverslip	NN	B-NP
was	was	VBD	0
placed	placed	VBN	0
perpendicularly	perpendicularly	VBN	0
to	to	TO	0
the	the	DT	0
flow	flow	NN	0
of	of	IN	0
perfusate	perfusate	NN	B-NP
.	.	.	0
A	A	DT	0
laminar	laminar	JJ	B-NP
arterial	arterial	JJ	I-NP
shear	shear	JJ	0
rate	rate	NN	0
of	of	IN	0
650	650	CD	0
s	s	NNS	0
-1was	-1was	VBP	0
achieved	achieved	VBN	0
based	based	VBN	0
on	on	IN	0
the	the	DT	0
dimensions	dimensions	NN	0
of	of	IN	0
the	the	DT	0
flow	flow	NN	B-NP
chamber	chamber	NN	I-NP
slit	slit	NN	I-NP
and	and	CC	0
a	a	DT	0
constant	constant	JJ	0
flow	flow	NN	B-NP
rate	rate	NN	I-NP
of	of	IN	0
10	10	CD	0
ml	ml	CD	B-NP
/	/	CD	I-NP
min	min	NN	I-NP
.	.	.	0
After	After	IN	0
preincubation	preincubation	NN	B-NP
at	at	IN	0
37°C	37°C	NNP	0
,	,	,	0
minimal	minimal	JJ	0
medium	medium	NN	0
was	was	VBD	0
drawn	drawn	VBN	0
directly	directly	RB	0
by	by	IN	0
an	an	DT	0
eight	eight	CD	0
roller	roller	NN	B-NP
peristaltic	peristaltic	NN	I-NP
pump	pump	VBP	0
through	through	IN	0
the	the	DT	0
perfusion	perfusion	JJ	B-NP
chamber	chamber	NN	I-NP
containing	containing	VBG	0
the	the	DT	0
BPAEC-covered	BPAEC-covered	JJ	B-NP
coverslip	coverslip	NN	I-NP
positioned	positioned	VBD	0
70	70	CD	0
mm	mm	NN	0
from	from	IN	0
the	the	DT	0
inlet	inlet	JJ	B-NP
valve	valve	NN	I-NP
at	at	IN	0
a	a	DT	0
rate	rate	NN	0
of	of	IN	0
10	10	CD	0
ml	ml	CD	B-NP
/	/	CD	I-NP
min	min	NN	I-NP
for	for	IN	0
either	either	DT	0
2	2	CD	0
min	min	NN	B-NP
or	or	CC	0
5	5	CD	0
min	min	NN	B-NP
.	.	.	0
A	A	DT	0
recirculating	recirculating	JJ	B-NP
system	system	NN	I-NP
was	was	VBD	0
employed	employed	VBN	0
to	to	TO	0
recycle	recycle	VB	0
the	the	DT	0
medium	medium	NN	0
after	after	IN	0
passing	passing	VBG	0
through	through	IN	0
the	the	DT	0
chamber	chamber	NN	0
.	.	.	0
prepared	prepared	VBN	B-NP
slide	slide	NN	I-NP
confocal	confocal	NN	I-NP
microscopy	microscopy	NN	I-NP
containing	containing	FW	0
adhered	adhered	VBN	B-NP
BPAEC	BPAEC	NNP	I-NP
were	were	VBD	0
examined	examined	VBN	0
using	using	VBG	0
a	a	DT	0
BioRad	BioRad	JJ	B-NP
confocal	confocal	JJ	I-NP
microscope	microscope	NN	I-NP
.	.	.	0
The	The	DT	0
cells	cells	NNS	0
were	were	VBD	0
imaged	imaged	VBN	0
following	following	VBG	0
rhodamine-phalloidin	rhodamine-phalloidin	JJ	B-NP
excitation	excitation	NN	I-NP
with	with	IN	0
an	an	DT	0
argon	argon	JJ	0
laser	laser	NN	0
beam	beam	NN	0
at	at	IN	0
a	a	DT	0
wavelength	wavelength	NN	0
of	of	IN	0
554	554	CD	0
nm	nm	NN	B-NP
using	using	VBG	0
either	either	RB	0
an	an	DT	0
inverted-	inverted-	JJ	0
or	or	CC	0
an	an	DT	0
uprighted-staged	uprighted-staged	JJ	B-NP
microscope	microscope	NN	I-NP
equipped	equipped	VBN	0
with	with	IN	0
either	either	RB	0
a	a	DT	0
10X	10X	NNP	0
or	or	CC	0
a	a	DT	0
20X	20X	JJ	0
oil-free	oil-free	JJ	0
objective	objective	NN	0
and	and	CC	0
an	an	DT	0
epifluorescent	epifluorescent	JJ	B-NP
illumination	illumination	JJ	I-NP
attachment	attachment	NN	I-NP
.	.	.	0
Cells	Cells	NNS	0
viewed	viewed	VBN	0
in	in	IN	0
representative	representative	JJ	B-NP
field	field	NN	I-NP
screen	screen	NN	I-NP
capture	capture	NN	I-NP
were	were	VBD	0
counted	counted	VBN	0
manually	manually	RB	0
for	for	IN	0
cell	cell	NN	0
morphology	morphology	NNS	0
and	and	CC	0
classified	classified	VBN	0
as	as	IN	0
either	either	DT	0
normal	normal	JJ	0
or	or	CC	0
elongated	elongated	NN	0
.	.	.	0
inhibitor	inhibitor	NN	B-NP
study	study	NN	I-NP
passage	passage	NN	I-NP
4-5	4-5	NNP	0
BPAEC	BPAEC	NNP	0
were	were	VBD	0
seeded	seeded	VBN	0
on	on	IN	0
plastic	plastic	JJ	B-NP
coverslip	coverslip	NN	I-NP
as	as	IN	0
described	described	VBN	0
above	above	IN	0
.	.	.	0
inhibitor	inhibitor	NN	B-NP
concentration	concentration	NN	I-NP
were	were	VBD	0
the	the	DT	0
same	same	JJ	0
as	as	IN	0
in	in	IN	0
[	[	-LRB-	0
28	28	CD	0
]	]	-RRB-	0
.	.	.	0
stock	stock	NN	B-NP
solution	solution	NN	I-NP
were	were	VBD	0
prepared	prepared	VBN	0
by	by	IN	0
dissolving	dissolving	VBG	0
the	the	DT	0
inhibitors	inhibitors	NN	0
in	in	IN	0
DMSO	DMSO	NNP	B-NP
.	.	.	0
The	The	DT	0
inhibitors	inhibitors	NN	0
used	used	VBN	0
and	and	CC	0
their	their	PRP$	0
stock	stock	NN	B-NP
solution	solution	NN	I-NP
were	were	VBD	0
as	as	RB	0
follows	follows	VBZ	0
:	:	:	0
quin2-AM	quin2-AM	CD	B-NP
(	(	-LRB-	0
Sigma	Sigma	NNP	B-NP
,	,	,	0
2	2	CD	0
mM	mM	NN	0
)	)	-RRB-	0
,	,	,	0
herbimycin	herbimycin	VBG	0
A	A	DT	0
(	(	-LRB-	0
GibcoBRL	GibcoBRL	NNP	B-NP
,	,	,	0
0.175	0.175	NNP	0
mM	mM	NNP	0
)	)	-RRB-	0
,	,	,	0
chelerythrina	chelerythrina	NN	B-NP
(	(	-LRB-	0
Sigma	Sigma	NNP	B-NP
,	,	,	0
0.4	0.4	CD	0
mM	mM	NN	0
)	)	-RRB-	0
,	,	,	0
cytochalasin	cytochalasin	VBG	0
D	D	NNP	0
(	(	-LRB-	0
Sigma	Sigma	NNP	B-NP
,	,	,	0
8	8	CD	0
μM	μM	NN	B-NP
)	)	-RRB-	0
,	,	,	0
nocodazola	nocodazola	NN	B-NP
(	(	-LRB-	0
Sigma	Sigma	NNP	B-NP
,	,	,	0
0.66	0.66	NNP	0
mM	mM	NNP	0
)	)	-RRB-	0
.	.	.	0
Quin2-AM	Quin2-AM	NNP	B-NP
,	,	,	0
herbimycin	herbimycin	VBG	0
A	A	DT	0
,	,	,	0
chelerythrine	chelerythrine	NN	B-NP
,	,	,	0
and	and	CC	0
cytochalasin	cytochalasin	JJ	0
D	D	NNP	0
were	were	VBD	0
stored	stored	VBN	0
at	at	IN	0
-20°C	-20°C	NNP	0
,	,	,	0
and	and	CC	0
nocodazola	nocodazola	NN	B-NP
was	was	VBD	0
stored	stored	VBN	0
at	at	IN	0
4°C	4°C	CD	0
.	.	.	0
The	The	DT	0
stock	stock	NN	B-NP
solution	solution	NN	I-NP
were	were	VBD	0
diluted	diluted	VBN	0
1	1	CD	0
:	:	:	0
200	200	CD	0
in	in	IN	0
minimal	minimal	JJ	B-NP
essential	essential	JJ	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
medium	medium	JJ	I-NP
to	to	TO	0
give	give	VB	0
the	the	DT	0
following	following	JJ	0
final	final	JJ	B-NP
concentration	concentration	NN	I-NP
:	:	:	0
quin2-AM	quin2-AM	CD	B-NP
(	(	-LRB-	0
10	10	CD	0
μM	μM	NN	B-NP
)	)	-RRB-	0
,	,	,	0
herbimycin	herbimycin	VBG	0
A	A	DT	0
(	(	-LRB-	0
875	875	CD	0
nM	nM	NN	B-NP
)	)	-RRB-	0
,	,	,	0
chelerythrina	chelerythrina	NN	B-NP
(	(	-LRB-	0
2	2	CD	0
μM	μM	NN	B-NP
)	)	-RRB-	0
,	,	,	0
cytochalasin	cytochalasin	VBG	0
D	D	NNP	0
(	(	-LRB-	0
40	40	CD	0
nM	nM	NN	B-NP
)	)	-RRB-	0
,	,	,	0
nocodazola	nocodazola	NN	B-NP
(	(	-LRB-	0
3.3	3.3	CD	0
μM	μM	NN	B-NP
)	)	-RRB-	0
.	.	.	0
Inhibitors	Inhibitors	NNP	0
were	were	VBD	0
applied	applied	VBN	0
24	24	CD	0
h	h	NN	B-NP
prior	prior	RB	I-NP
to	to	TO	0
the	the	DT	0
resveratrol	resveratrol	NN	B-NP
addition	addition	NN	I-NP
,	,	,	0
except	except	IN	0
for	for	IN	0
quin2-AM	quin2-AM	NNP	B-NP
,	,	,	0
which	which	WDT	0
was	was	VBD	0
applied	applied	VBN	0
1	1	CD	0
h	h	NN	B-NP
prior	prior	RB	I-NP
to	to	TO	0
resveratrol	resveratrol	VB	0
treatment	treatment	NN	0
.	.	.	0
Since	Since	IN	0
cells	cells	NNS	0
treated	treated	VBN	0
with	with	IN	0
various	various	JJ	0
inhibitors	inhibitors	NN	0
grew	grew	VBD	0
less	less	RBR	0
well	well	RB	0
,	,	,	0
compared	compared	VBN	0
to	to	TO	0
controls	controls	NNS	0
,	,	,	0
treatment	treatment	NN	0
with	with	IN	0
100	100	CD	0
μM	μM	JJ	B-NP
resveratrol	resveratrol	NN	I-NP
was	was	VBD	0
reduced	reduced	VBN	0
to	to	TO	0
approximately	approximately	RB	0
40	40	CD	0
h	h	NNS	0
.	.	.	0
Fixing	Fixing	NNP	0
and	and	CC	0
staining	staining	NN	0
of	of	IN	0
cells	cells	NNS	0
for	for	IN	0
confocal	confocal	JJ	B-NP
microscopy	microscopy	NN	I-NP
was	was	VBD	0
as	as	RB	0
described	described	VBN	0
above	above	IN	0
.	.	.	0
Western	Western	JJ	0
blot	blot	JJ	0
analysis	analysis	NN	0
Control	Control	NNP	0
and	and	CC	0
treated	treated	JJ	0
cells	cells	NNS	0
were	were	VBD	0
lysed	lysed	VBN	0
by	by	IN	0
repeated	repeated	VBN	B-NP
freeze-thaw	freeze-thaw	JJ	I-NP
cycle	cycle	NN	I-NP
with	with	IN	0
buffer	buffer	NN	B-NP
containing	containing	VBG	0
10	10	CD	0
mm	mm	NN	B-NP
hepe	hepe	NN	I-NP
(	(	-LRB-	0
pH	pH	NNP	B-NP
7.5	7.5	CD	0
)	)	-RRB-	0
,	,	,	0
1.5	1.5	CD	0
mM	mM	JJ	B-NP
Mg	Mg	NNP	I-NP
(	(	-LRB-	I-NP
OAc	OAc	NNP	I-NP
)	)	-RRB-	I-NP
2	2	CD	0
,	,	,	0
1	1	CD	0
mM	mM	JJ	B-NP
dithiothreitol	dithiothreitol	NN	I-NP
(	(	-LRB-	0
DTT	DTT	NNP	B-NP
)	)	-RRB-	0
,	,	,	0
0.5	0.5	CD	0
%	%	NN	0
NP40	NP40	NN	B-NP
,	,	,	0
5	5	CD	0
%	%	NN	0
glycerol	glycerol	NN	B-NP
,	,	,	0
0.5	0.5	CD	0
mM	mM	JJ	0
phenylmethylsulfonyl	phenylmethylsulfonyl	JJ	B-NP
fluoride	fluoride	NN	I-NP
,	,	,	0
and	and	CC	0
10	10	CD	0
μg	μg	CD	B-NP
/	/	CD	I-NP
ml	ml	CD	I-NP
each	each	DT	0
of	of	IN	0
the	the	DT	0
aprotinin	aprotinin	NN	B-NP
protease	protease	JJ	I-NP
inhibitor	inhibitor	NN	I-NP
,	,	,	0
pepstatin	pepstatin	NN	B-NP
,	,	,	0
and	and	CC	0
leupeptin	leupeptin	NN	B-NP
.	.	.	0
cell-free	cell-free	NN	B-NP
extract	extract	NN	I-NP
were	were	VBD	0
obtained	obtained	VBN	0
by	by	IN	0
centrifugation	centrifugation	NN	B-NP
in	in	IN	0
a	a	DT	0
microcentrifuge	microcentrifuge	NN	B-NP
.	.	.	0
lysate	lysate	NN	B-NP
(	(	-LRB-	0
7-10	7-10	FW	0
μg	μg	NN	B-NP
)	)	-RRB-	0
from	from	IN	0
control	control	NN	0
and	and	CC	0
treated	treated	JJ	0
cells	cells	NNS	0
were	were	VBD	0
separated	separated	VBN	0
on	on	IN	0
10	10	CD	0
%	%	NN	0
SDS-PAGE	SDS-PAGE	NN	B-NP
.	.	.	0
The	The	DT	0
separated	separated	JJ	0
proteins	proteins	NNS	0
were	were	VBD	0
transferred	transferred	VBN	0
to	to	TO	0
nitrocellulose	nitrocellulose	VB	0
membranes	membranes	NNS	0
,	,	,	0
and	and	CC	0
the	the	DT	0
membranes	membranes	NN	0
were	were	VBD	0
incubated	incubated	VBN	0
with	with	IN	0
the	the	DT	0
respective	respective	JJ	0
primary	primary	JJ	0
and	and	CC	0
secondary	secondary	JJ	B-NP
antibody	antibody	NN	I-NP
.	.	.	0
The	The	DT	0
monoclonal	monoclonal	JJ	B-NP
primary	primary	JJ	I-NP
antibody	antibody	NN	I-NP
used	used	VBN	0
and	and	CC	0
their	their	PRP$	0
dilutions	dilutions	NN	0
were	were	VBD	0
as	as	RB	0
follows	follows	VBZ	0
:	:	:	0
Phosphorylated	Phosphorylated	NNP	0
,	,	,	0
active	active	JJ	0
ERK1	ERK1	CD	B-NP
/	/	CD	0
2-P	2-P	CD	B-NP
(	(	-LRB-	0
RBI	RBI	NNP	B-NP
/	/	NNP	I-NP
Sigma	Sigma	NNP	I-NP
,	,	,	0
1	1	CD	0
:	:	:	0
1000	1000	CD	0
)	)	-RRB-	0
,	,	,	0
total	total	JJ	B-NP
ERK1	ERK1	CD	I-NP
/	/	CD	0
2	2	CD	0
(	(	-LRB-	0
RBI	RBI	NNP	B-NP
/	/	NNP	I-NP
Sigma	Sigma	NNP	I-NP
,	,	,	0
1	1	CD	0
:	:	:	0
1000	1000	CD	0
)	)	-RRB-	0
,	,	,	0
eIF4E	eIF4E	NNP	0
(	(	-LRB-	0
Santa	Santa	NNP	0
Cruz	Cruz	NNP	0
,	,	,	0
1	1	CD	0
:	:	:	0
250	250	CD	0
)	)	-RRB-	0
,	,	,	0
enzyme	enzyme	NN	B-NP
nitric	nitric	JJ	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
oxide	oxide	NN	I-NP
synthase	synthase	NN	I-NP
(	(	-LRB-	0
Sigma	Sigma	NNP	B-NP
1	1	CD	0
:	:	:	0
1000	1000	CD	0
)	)	-RRB-	0
.	.	.	0
Membranes	Membranes	NNP	0
were	were	VBD	0
probed	probed	VBN	0
with	with	IN	0
alkaline	alkaline	JJ	B-NP
phosphatase-conjugated	phosphatase-conjugated	JJ	I-NP
IgG	IgG	NN	I-NP
(	(	-LRB-	0
Santa	Santa	NNP	0
Cruz	Cruz	NNP	0
,	,	,	0
1	1	CD	0
:	:	:	0
1500	1500	CD	0
)	)	-RRB-	0
or	or	CC	0
horseradish	horseradish	JJ	B-NP
peroxidase-conjugated	peroxidase-conjugated	JJ	I-NP
IgG	IgG	NN	I-NP
(	(	-LRB-	0
Santa	Santa	NNP	0
Cruz	Cruz	NNP	0
,	,	,	0
1	1	CD	0
:	:	:	0
2000	2000	CD	0
)	)	-RRB-	0
.	.	.	0
specific	specific	JJ	B-NP
immunoreactive	immunoreactive	JJ	I-NP
band	band	NN	I-NP
were	were	VBD	0
identified	identified	VBN	0
by	by	IN	0
color	color	NN	B-NP
reaction	reaction	NN	I-NP
or	or	CC	0
enhanced	enhanced	JJ	0
chemiluminescence	chemiluminescence	NN	B-NP
,	,	,	0
respectively	respectively	RB	0
.	.	.	0
